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Summary 
 
A large proportion of human pregnancies have the wrong number of 
chromosomes, known as aneuploidy, with the chances of having an affected 
pregnancy increasing with maternal age. The majority of these errors can be 
traced back to the egg (oocyte), which undergoes two meiotic cell divisions to 
generate a cell with half the number of chromosomes of a somatic cell. The first 
meiotic division is particularly error-prone and accounts for a significant 
proportion of aneuploidies in early embryos. This first division is a unique form 
of cell division because it entails separation of homologous chromosome pairs 
and co-segregation of identical sister chromatids at anaphase (in mitosis and 
meiosis II, by contrast, sister chromatids separate at anaphase). The 
kinetochore is a multiprotein structure that assembles on the centromeres of 
chromosomes and facilitates chromosome segregation by forming attachments 
to spindle fibres emanating from one of the spindle poles. For a successful 
meiosis I division, kinetochores on sister chromatids must act as a single 
functional unit. In mouse and yeast this is achieved through close physical 
association of meiotic sister kinetochores; in humans, however, little is known 
about the arrangement of sisters in oocytes, largely due to the limited availability 
of human oocytes for research. In this project, I show that in human meiosis I 
stage oocytes donated to research by women undergoing assisted 
reproduction, sister kinetochores are not physically fused and are each capable 
of forming individual attachments to spindle microtubule fibres. I also found a 
significant increase in the distance between sister kinetochores in patients over 
35 years of age, which may indicate a decline in inter-kinetochore cohesion over 
time. These unique features of sister kinetochore geometry in human oocytes 
may shed light on why meiosis in humans is susceptible to error with increasing 
maternal age. 
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Chapter 1: Introduction 
In humans, the chance of having a pregnancy with the wrong number of 
chromosomes, a state known as aneuploidy, increases dramatically with 
maternal age. In women under 25 years of age, around 2% of all clinically 
recognised pregnancies are trisomic (have an additional chromosome), 
however this figure rises to 35% for women over 40 (Hassold & Chiu, 1985). 
Aneuploidy is a leading cause of early miscarriage, as the presence of an extra 
or a missing chromosome is usually incompatible with normal development. 
Although some pregnancies with certain chromosomes in incorrect numbers 
can survive to term, including the sex chromosomes and trisomies 13, 18 and 
21, they often result in infants with severe medical problems. With increasing 
numbers of women choosing to have children at later ages, there has been 
increased focus on understanding the factors that contribute to this 
phenomenon. 
What we know so far is that the vast majority of aneuploidies in pregnancy are 
of maternal origin and arise from chromosome segregation errors that occur 
during the meiotic divisions of the oocyte, in particular the first meiotic division 
(Hassold et al., 2007). That this first meiotic division is responsible for the 
majority of aneuploidies is perhaps not surprising given that it has a number of 
features that differentiate it from a standard equational division that occurs in 
mitosis and meiosis II. Unlike an equational division in which sister chromatids 
are separated, the first meiotic division comprises segregation of homologous 
chromosome pairs (i.e. the maternally- and paternally-inherited copies of each 
chromosome). For this to happen successfully requires a unique set of 
chromosomal events to occur, including: (1) resolution of DNA crossovers that 
physically tether the homologues to one another; (2) protection of centromeric 
cohesion between sister chromatids so that they remain together during 
anaphase; and (3) attachment of sister kinetochores to the same, rather than 
opposing, spindle poles. Failure or mistiming of any of these events can lead to 
chromosome missegregation at anaphase I. In addition to these events, human 
1
oocyte meiosis I is further complicated by the fact that there is a long gap 
between initiation of meiosis, which occurs during fetal life, and completion of 
the first meiotic division, which occurs many years later just before ovulation. In 
human oocyte meiosis I, we have limited understanding of how kinetochores, 
multisubunit protein structures that constitute the physical interface between 
chromosomes and the spindle, form attachments to the same spindle pole. 
Further understanding of the geometry and architecture of the human meiotic 
kinetochore during this highly error-prone division is therefore required. 
1.1. Meiosis 
Meiosis is a specialised form of cell division that involves the generation of 
haploid gametes from diploid precursor cells, and is a key prerequisite for all 
sexually reproducing organisms. During meiosis, recombination between 
maternally- and paternally-inherited chromosomes results in novel 
combinations of genes that are crucial for the diversity of life. At the 
chromosomal level, meiosis is fundamentally similar between species and 
sexes, beginning with doubling of cellular DNA content through DNA replication, 
followed by two rounds of cell division, generating cells that have half the DNA 
content of a somatic cell. The first meiotic division is a reductional division in 
which paired homologous chromosomes (the maternally- and paternally-
inherited copy of each chromosome), connected by crossovers formed during 
meiotic recombination, separate (see Figure 1.1). The second meiotic division 
more closely resembles a mitotic division in which sister chromatids are 
separated. 
1.1.1. From primordial germ cells to oogonia 
Although the fundamental features of meiosis are shared, there are a number 
of aspects of human female meiosis that differentiate it from male meiosis. One 
key difference is the timing of entry into meiosis. In both males and females, at 
around 6–8 weeks of development, primordial germ cells migrate to the 
developing gonads of the embryo, where after several rounds of mitotic 
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proliferation they differentiate into oogonia (females) or gonocytes (males). In 
males, gonocytes go on to divide mitotically and differentiate into 
prespermatogonia which remain mitotically quiescent for several years, only 
entering meiosis upon reaching puberty many years later. In females, however, 
oogonia begin to enter meiosis at around 10–11 weeks of gestation, developing 
into primary oocytes (see Figure 1.2). Up to 5 months, it is possible to observe 
both oogonia and primary oocytes in the fetal ovary, indicating that there is 
overlap between the period of mitotic proliferation and entry into meiosis. This  
asynchrony in meiotic entry appears to be linked to spatial features of the ovary, 
with an anterior-to-posterior gradient of meiotic initiation that arises due to 
retinoic acid signalling (Suzuki et al., 2015). By the time mitotic proliferation 
ceases, there are an estimated 10 million oogonia in the fetal ovary (De Felici, 
2013).  
Dividing oogonia form clusters of cells that are joined by cytoplasmic bridges 
which arise as a result of incomplete cell division; these clusters are known as 
germline cysts (De Felici, 2013). During neonatal development, these cysts 
break down and fragment into smaller cysts, eventually forming a single oocyte 
surrounded by a layer of pregranulosa cells, also known as a primordial follicle 
(Lei & Spradling, 2013). During the process of cyst breakdown, a large 
proportion of cells within the cyst die by apoptosis, with approximately one third 
surviving (Pepling, 2013). The reasons for this large amount of cell death are 
not clear, but one theory is that it may ensure that cells destined to become 
primary oocytes acquire sufficient numbers of mitochondria (Pepling & 
Spradling, 2001). There are also spatial differences in germ cell cyst breakdown, 
with cysts in the medulla (inner part) of the ovary entering meiosis first and being 
the first to form follicles; this has been observed in mammals including mouse, 
rats and humans (Hirshfield, 1992, Wang et al., 2017). In humans, the first wave 
of oocytes that enter development do not end up being ovulated because by the 
time they develop it is too early for them to be rescued by a gonadotrophin 
surge, so they die as atretic follicles (Mazaud et al., 2002). The reasons for this 
apparent wastage in the first wave of follicular development are not known. 
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Figure 1.1. Chromosome segregation in mitosis and meiosis I. (a) In mitosis, 
kinetochores on sister chromatids form attachments to kinetochore-fibres (k-fibres) 
emanating from opposite spindle poles, resulting in segregation of sister chromatids at 
anaphase. (b) Meiosis I, on the other hand, entails separation of homologous chromosome 
pairs (represented here in blue and red), therefore sister kinetochores form attachments to 
k-fibres from the same spindle pole. This ensures that they co-segregate to the same spindle
pole during anaphase I.
Figure 1.1
a  Mitosis
b  Meiosis I
microtubule
spindle 
pole
kinetochore
sister chromatids
sister chromatids
Metaphase Anaphase
Metaphase I Anaphase I
homologues
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Figure 1.2. Oocyte development from fetal life to ovulation. Oocyte life begins early in 
fetal development when primordial germ cells divide mitotically to increase their numbers. At 
11–13 weeks of gestation, these primordial germ cells begin to enter meiosis, forming 
primordial follicles which consist of an oocyte surrounded by a single layer of flattened 
pre-granulosa cells. Most of these primordial follicles remain quiescent or undergo atresia 
(cell death), but a subset become activated in response to molecular cues, which results in 
their development and growth into primary, then secondary and finally antral follicles. At 
puberty, the pulsatile release of follicle-stimulating hormone (FSH) results in the selection of 
a single dominant follicle, which is ovulated mid-cycle following a surge in luteinising hormone 
(LH). Follicles that do not receive this stimulation undergo atresia.
Figure 1.2
Fetal life Birth Puberty
Mitotic proliferation
Meiotic entry
Germ cell 
death
Follicle formation
Ovulation
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1.1.2. Chromosomal events in early meiosis 
Entry into meiosis marks several important events at the chromosomal level. 
Meiosis follows the same stages of cell division as mitosis: prophase, 
metaphase, anaphase, telophase and cytokinesis. The first prophase in 
females, however, is a highly extended process, that includes a prolonged 
arrest that can last from 10–40 years. This stage has classically been divided 
into five substages, based on the distinct chromosome morphology that can be 
seen at each stage. During the first stage, leptotene (Greek for ‘thin threads’), 
chromosomes can be visualised as long, thin strands that have begun to 
condense but have not yet paired with their homologous partners in the cell (see 
Figure 1.3). At this stage, components of the cohesin complex which mediates 
cohesion between sister chromatids begin to assemble along chromosome 
arms (Prieto et al., 2004). These elements form a chromosomal scaffold that 
helps to recruit other essential proteins to the chromosomes during this period 
(Handel & Schimenti, 2010). Finding and pairing with homologous partners 
occurs in the next stage of prophase I, zygotene (‘paired threads’), a process 
that depends upon sequence homology alignment (Gerton & Hawley, 2005). 
Synapsis between homologues is mediated by the synaptonemal complex (SC), 
a proteinaceous structure that forms a ladder-like assembly between 
homologous chromosomes. (Page & Hawley, 2004). Synaptonemal complex 
proteins 2 and 3 (SYCP2 and SYCP3) make up the lateral elements of the 
structure and assemble along chromosome arms in a cohesin-dependent 
manner (Prieto et al., 2004). Other SC components, including SYCP1, localise 
to the central region between chromosomes, forming the rungs of the ladder 
structure (Handel & Schimenti, 2010). By pachytene (‘thick threads’), SC 
assembly is complete and chromosomes are fully synapsed, enabling DNA 
crossovers, or chiasmata, to form. At diplotene (‘two threads’), the SC 
disassembles and chromosomes move apart slightly, now connected by 
chiasmata, where they are held for many years in an extended arrest state. 
Assembly of the SC is essential for reciprocal recombination between maternal 
and paternal copies of each chromosome, which is crucial for keeping 
homologues together during the long arrest period and for generating 
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Figure 1.3. Stages of meiotic prophase I. The first meiotic prophase begins with the 
leptotene (Greek for ‘thin threads’) stage, in which chromosomes can be visualised as thin 
strands. Cohesin (green) begins to assemble along chromosome arms, forming a 
chromosomal scaffold. Leptotene is followed by zygotene (‘paired threads’), in which 
homologous chromosomes begin to pair up and synaptonemal complex (SC) elements begin 
to assemble along chromosome arms (orange). By pachytene (‘thick threads’), chromosomes 
are completely synapsed and formation of the SC is complete. At diplotene (‘two threads’) 
homologues move apart slightly but remain tethered together by chiasmata. They are held in 
this stage until ovulation, which can occur between 10–40 years later, when they reach 
diakinesis (‘moving through’). At this stage, the nuclear envelope breaks down, chromosomes 
condense and the first meiotic spindle begins to assemble.
Figure 1.3
Leptotene Zygotene Pachytene Diplotene Diakinesis
nuclear envelope 
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chromosomes with novel combinations of genes. The process of crossover 
formation has many similarities with homologous repair of DNA double-stranded 
breaks and shares many of the proteins involved in this mechanism of DNA 
repair. It begins in leptotene with the formation of Spo11-induced double-
stranded breaks in chromosomes (Keeney et al., 1997), which attract the 
mismatch repair proteins MLH1 and MLH3 that promote crossing-over (Lipkin 
et al., 2002, Lenzi et al., 2005). Break formation is followed by exonucleolytic 
resection of the 5’ ends of the break which results in two 3’ single-stranded 
overhangs. One of these overhangs invades into the aligned region of its 
homologous partner, displacing a strand of DNA which forms what is known as 
a D-loop structure (Figure 1.4). This D-loop captures the other 3’ end (Hunter 
& Kleckner, 2001). The ends of the 3’ overhangs are then extended by DNA 
synthesis, using the homologous chromosome partner’s DNA as a template, 
eventually resulting in formation of a double Holliday junction (Schwacha & 
Kleckner, 1995, Gerton & Hawley, 2005, Handel & Schimenti, 2010). This 
double Holliday junction forms a physical linkage between homologous 
chromosomes known as a chiasma. When the SC disassembles during the 
diplotene stage of meiotic prophase I, chiasmata are responsible for keeping 
homologues tethered to each other for the duration of the extended arrest period 
that follows. The resulting chromosome structure is known as a bivalent, which 
consists of a pair of homologous chromosomes (each comprising a pair of sister 
chromatids) held together by chiasmata. 
1.1.3. Follicular growth during the arrest period 
During arrest at diplotene of meiotic prophase I, oocytes are located within 
primordial follicles, which comprise a meiotically arrested oocyte surrounded by 
a single layer of somatic pre-granulosa cells which have a flattened appearance 
(Pepling, 2006). These primordial follicles constitute the total pool of oocytes 
from which oocytes are then selected for further development. The transition 
from a primordial follicle to a primary oocyte is known as primordial follicle 
activation. Over the course of a woman’s life, only a small fraction 
(approximately 1 in 1600) of primordial follicles will be recruited for activation. 
The rest will remain quiescent within the ovary, or they will undergo atresia (cell 
8
End extension and 
recapture
Strand invasion
Spo11-induced DSB
5’ exoucleolytic 
resection
double Holliday junction
3’
3’
3’
5’
5’
3’
Figure 1.4. The process of crossover formation during meiotic recombination. During 
leptotene, homologous chromosomes (shown in purple and orange) become aligned. The 
process of crossover formation begins with the formation of double-stranded breaks (DSBs) 
in DNA which are introduced by the highly conserved Spo11 protein. An exonuclease (light 
green) resects DNA in a 3'-5' direction, resulting in two 3' single-stranded overhangs. One of 
these invades into the homologous partner, displacing a strand of DNA which forms a D-loop 
structure. The D-loop captures the other 3' ssDNA strand. The strand is extended by DNA 
synthesis, recapturing the other end of the break and resulting in formation of a double 
Holliday junction. Adapted from Gerton & Hawley (2005).
Figure 1.4
Alignment
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death), a process that can occur after activation or directly from quiescence. 
During fetal life, a vast proportion of follicles undergo atresia, which reduces the 
total pool of germ cells from 7 million to around 2 million at birth (Pepling, 2013). 
This process is thought to eliminate cells with DNA damage or other defects, 
although little is known beyond this. Although some of the molecular signals 
involved in maintenance of follicular quiescence or follicle activation have been 
identified, including anti-Mullerian hormone, the tumour suppressor protein 
PTEN and FOXO3a, all of which are involved in maintenance of quiescence, 
little is known about the overall cues that determine follicular fate. Over the 
course of a woman’s life, only a very small percentage (<1%) of cells that 
undergo meiotic initiation make it to ovulation and completion of the first meiotic 
division, which suggests an overall inefficient process (Adhikari & Liu, 2013). 
However, this apparent inefficiency may have some purpose that is not currently 
understood. 
The small fraction of follicles that become recruited to grow follow a process of 
development that begins with growth into primary, then secondary, then antral 
follicles. The first follicles begin to grow in humans at around 4 months of fetal 
life, with approximately 1000 follicles per month recruited for growth (Macklon & 
Fauser, 1999). During the early growth period of the follicle, the pre-granulosa 
cells of the primordial follicle differentiate and proliferate to form layers around 
the oocyte. This process is accompanied by an increase in oocyte size, 
formation of a zona pellucida around the oocyte, and accumulation of mRNA in 
the ooplasm (Gougeon, 2013). When the oocyte is surrounded by two layers of 
granulosa cells, it is known as a secondary follicle. Gap junctions between the 
granulosa cells and the oocyte facilitate cross-communication and signalling 
which are essential for the oocyte’s growth and development (Anderson & 
Albertini, 1976, Eppig, 2001). Progression from a secondary follicle to an antral 
follicle is characterised by the formation of a fluid-filled cavity adjacent to the 
oocyte (the antrum). During this period of early follicular development the oocyte 
experiences its most rapid growth, increasing from a diameter of 40 µm at the 
primary follicle stage to 100 µm at the early antral stage (Gougeon, 2013). 
Throughout this period of follicular growth, the oocyte remains in meiotic 
prophase I arrest, maintenance of which appears to be achieved through low 
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concentrations of the cell cycle protein CDK1 (cyclin dependent kinase 1). 
Oocytes less than 80% of their full size are incapable of undergoing meiotic 
resumption, which is most likely linked to an inability to build up sufficient CDK1 
levels to trigger entry into anaphase (Jones et al., 2013). 
 
1.1.4. Meiotic resumption and fertilisation 
 
In humans, multiple early antral follicles are present during each reproductive 
cycle, however prior to puberty they do not receive enough stimulation to 
develop into a fully mature oocyte. At puberty, increased exposure to follicle-
stimulating hormone (FSH) and changes in its pulse frequency and amplitude 
result in the selection of a single dominant follicle, based upon differential 
sensitivity to FSH among the follicles of a cohort, and mediated by follicular 
products such as oestradiol and inhibin feeding back to the pituitary gland to 
regulate gonadotrophin production (Carey & Murray, 2006). Follicles that 
receive insufficient FSH undergo atresia, a  process that is mediated by 
apoptosis of surrounding granulosa cells (Hsueh & Kawamura, 2013). The 
selected oocyte develops within its antral cavity, surrounded by cumulus cells 
which are connected to mural granulosa cells via gap junctions (Carabatsos et 
al., 2000). A surge in luteinising hormone (LH) from the pituitary gland towards 
the middle of the menstrual cycle triggers ovulation and meiotic resumption. The 
transition of the oocyte from prophase I to metaphase I (MI) is characterised by 
a number of CDK1-mediated events, including chromosome condensation, 
breakdown of the germinal vesicle (GV; the oocyte nucleus at prophase I arrest) 
and formation of the first meiotic spindle (Jones et al., 2013). The first live-cell 
imaging study following human oocytes from GV breakdown to the first meiotic 
division has shown that the period of spindle assembly lasts for approximately 
16 hours (Holubcova et al., 2015), significantly longer than in mouse in which 
the process takes about 3–5 hours (Schuh & Ellenberg, 2007). Upon completion 
of the first meiotic division, during which the oocyte releases its first polar body, 
there is no intervening S-phase and the oocyte assembles the second meiotic 
spindle. Only oocytes in the metaphase II (MII) stage of meiosis are capable of 
being fertilised. Completion of the second meiotic division occurs during 
fertilisation in response to calcium (Ca2+) oscillations, which are triggered when 
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a spermatozoon has passed through the zona pellucida and fused with the 
oolemma. 
 
1.1.5. An overview of the IVF/ICSI process 
 
In vitro fertilisation (IVF) treatment is widely used for couples experiencing 
infertility. The first IVF baby was born in 1978 (Steptoe & Edwards, 1978) 
following many years of research in animals and studying human eggs and 
sperm in vitro (Edwards, 1965, Edwards et al., 1969). IVF entails collecting 
oocytes from women, fertilising them in the laboratory, and returning one or 
more embryos to the uterus in an attempt to initiate pregnancy.  Currently the 
overall success rate in UK is around 25% per cycle (HFEA, 2016).  
 
Women undergoing IVF first undergo hormonal ovarian stimulation, which 
involves treatment with exogenous gonadotrophins to promote the growth of 
multiple follicles in vivo and cotreatment with a gonadotrophin-releasing 
hormone (GnRH) analog to prevent an LH surge (Cheong et al., 2012). This can  
be done in one of two ways. The first approach involves treatment with a 
superactive GnRH agonist, which downregulates pituitary GnRH receptors and 
renders the pituitary gland unresponsive to GnRH, allowing FSH to be 
administered in controlled doses without risk of an LH surge causing premature 
ovulation (Griesinger et al., 2006). The second involves use of a GnRH 
antagonist, which directly interferes with GnRH stimulation by competitively 
binding to GnRH receptors, thus preventing the LH surge, but not 
downregulating GnRH receptors at the pituitary and not depleting endogenous 
FSH or LH (Macklon et al., 2006, Tarlatzis et al., 2006).  Both approaches result 
in multiple growth of follicles in numbers that reflect the number of small antral 
follicles available at the start of the menstrual cycle in which treatment is 
provided, which in turn relates to a woman’s age. The follicles do not ovulate or 
undergo atresia because supraphysiological FSH levels are maintained without 
follicular products triggering an LH surge.  
 
When the growing follicles have reached a diameter of approximately 16–18 
mm, as observed by transvaginal ultrasound, the eggs are collected by 
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aspirating the follicles in the ovary, with the patient under sedation, using an 
ultrasound-guided transvaginal needle (Barton & Ginsburg, 2012). Upon 
collection, oocytes are surrounded by granulosa cells comprising the cumulus-
oocyte complex. For IVF treatment, collected oocytes are typically incubated for 
16–18 hours with prepared sperm from the male partner or donor. In some 
cases, depending on patient history or sperm quality, intracytoplasmic sperm 
injection (ICSI) is performed to promote fertilisation, which entails the injection 
of a single immobilised sperm into the ooplasm. ICSI entails removing the 
surrounding cumulus cells prior to sperm injection, whereas in IVF the cumulus 
is not removed until the following day (Maggiulli et al., 2012, Palermo et al., 
2012). Following overnight culture, oocytes are assessed under light 
microscopy for signs of fertilisation. Normal fertilisation is assumed when two 
pronuclei are visible and the oocyte has extruded the second polar body, thus 
completing the second meiotic division. The two pronuclei normally contain 
haploid complements of maternal and paternal DNA. Oocytes that do not 
fertilise, or which fertilise abnormally, are not usable clinically and are normally 
discarded. Such oocytes include those which are immature (containing a GV or 
having failed to produce the first polar body), unfertilised (showing no pronuclei), 
abnormally fertilised (e.g. containing multiple pronuclei or one pronucleus), may 
be parthenogenetic or have fused pronuclei, or have failure of one pronucleus 
to develop. Since these decisions are made solely based upon light microscopic 
observation and no detailed chromosomal assessment, the categories assigned 
may not always be correct.  
 
The fertilisation check is the time at which oocytes may become available for 
research use, provided that patient consent has been previously obtained. For 
ICSI cycles, immature oocytes may be available earlier, because only MII-stage 
oocytes are suitable for sperm microinjection. The normally fertilised oocytes 
are cultured for several days with frequent monitoring until an embryo can be 
selected for transfer into the patient.  Embryo culture to the blastocyst stage, 5-
6 days, is applied in order to aid the embryo selection process (Maggiulli et al., 
2012). 
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1.2. Aneuploidy in human oocytes 
 
1.2.1. Early investigations into human aneuploidy 
 
Although the link between Down’s syndrome and maternal age was first 
identified in the 1930s, it was not until the late 1950s that the presence of an 
additional copy of chromosome 21 was identified as the cause of the syndrome 
(Jacobs et al., 1959). Following this discovery, karyotyping studies conducted 
over the next few decades found that in over 60,000 newborns, the incidence 
aneuploidy was 0.3%. Of these, trisomy 21 was the most common, followed by 
trisomy of the sex chromosomes and chromosomes 13 and 18, whereas the 
incidence of aneuploidy in the remaining autosomes was almost non-existent 
(Hassold et al., 1996). In stillbirths (between 20 weeks gestation and term), the 
incidence increased to approximately 4%, but the chromosome-specific trends 
in trisomy remained the same with trisomy 21 again the most commonly 
identified aneuploidy (reviewed in Nagaoka et al., 2012). However, as this data 
was only from pregnancies after 20 weeks, with no data from earlier stages of 
pregnancy, it did not provide a comprehensive picture of aneuploidy in human 
pregnancy. During the 1970s and 1980s researchers were able to study 
spontaneous abortions that occurred between 6 weeks and 20 weeks, which 
found much higher incidences of trisomy of over 35%, with almost all 
chromosomes involved, but trisomy 16 being the most common (Hassold et al., 
1996). These early-stage fetuses also contained trisomies that were rarely 
observed in newborns or stillbirths, such as sex chromosome monosomy and 
trisomy of chromosomes 2, 14, 15 and 22 (Hassold et al., 1996). These data 
provided the first major indication that chromosomal abnormalities were one of 
the leading causes of miscarriage and congenital birth defects. Using this 
information, it was possible to derive a minimal estimate of aneuploidy of 
approximately 5% of all conceptions (Hassold & Hunt, 2001). However, as it 
was likely that many chromosomally abnormal pregnancies spontaneously 
abort prior to clinical detection (earlier than 6 weeks gestation), the true 
incidence was estimated to be much higher.  
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1.2.2. Aneuploidy in assisted reproduction cycles 
 
The introduction of IVF in the 1980s meant that it became possible for the first 
time to study human oocytes and human embryos at the earliest stages of 
development. A number of preimplantation genetic diagnosis (PGD) protocols 
were developed during this period to enable detection of chromosomal 
abnormalities in human oocytes and early embryos. Often these involved taking 
biopsies of the first and/or second polar bodies to work out the chromosomal 
complement of the oocyte or embryo (reviewed in Nagaoka et al., 2012). Study 
of these polar bodies began through fluorescence in situ hybridisation (FISH), 
in which a labelled chromosome-specific probe was used to detect individual 
chromosomes in spreads generated from the cell of interest. A review of over 
60 studies using chromosome karyotyping and FISH in MII oocyte chromosome 
spreads suggested an overall incidence of aneuploidy in human oocytes of 20–
30% (Pellestor et al., 2005), which was in agreement with results obtained from 
spontaneous abortions. However, there was significant variation between 
studies which was likely to be attributable to technical limitations in the methods 
used to identify chromosomal abnormalities. In particular, these methods relied 
on accurate scoring of chromosomes in spreads and the ability to distinguish 
single chromatids from small chromosomes.  
 
Another method of analysing chromosomal abnormalities that was developed 
for PGD includes comparative genomic hybridisation (CGH), in which test and 
control DNA are differentially labelled and then competitively hybridised to 
normal metaphase chromosomes. The ratio of the control and test DNA 
samples can be measured along the length of the chromosome, which can give 
an indication if there is a chromosomal loss or gain. Initial studies using CGH in 
oocytes and embryos indicated many advantages over FISH because the 
method enabled all chromosomes to be analysed at once, and thus could detect 
abnormalities that were likely to have been missed by FISH (Voullaire et al., 
2000, Wells et al., 2002, Wilton et al., 2003). However, the time-consuming 
nature of the procedure meant that it was gradually replaced with array CGH 
(aCGH), in which DNA is hybridised to probes on microarrays, and single 
nucleotide polymorphism (SNP) arrays, which enable detection of crossover 
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location and parental origin of aneuploidy. The use of these methods in PGD 
revealed an incidence of aneuploidy in pregnancy of between 10–40% (Fragouli 
et al., 2008, Fragouli et al., 2011, Treff et al., 2011), figures which are in keeping 
with initial cytogenetic studies into human aneuploidy from natural conceptions. 
Moreover, they also found that there was overrepresentation of 
small/acrocentric chromosomes, including 13, 18 and 21, and the sex 
chromosomes (Nagaoka et al., 2012).  
 
1.2.3. Endocrine origins of missegregation 
 
A caveat of the work from oocytes derived from assisted reproductive 
technology (ART) cycles is that they are not representative of the normal 
population: they are from a population of infertile women, the oocytes come from 
hyperstimulated ovaries, and moreover the oocytes studied are those that have 
failed in IVF. A particular concern is the effect of ovarian hyperstimulation on 
aneuploidy. Most of the oocytes on which our estimations of aneuploidy 
incidence are based came from cycles of IVF in which patients were exposed 
to an ovarian stimulation regimen involving treatment with exogenous FSH. FSH 
binds to its receptors which are exclusively found on  granulosa cells 
(O'Shaughnessy et al., 1996) which communicate bidirectionally with the oocyte 
to regulate follicular development and oocyte maturation (Eppig, 2001). There 
have therefore been concerns that exposure of oocytes to supraphysiological 
levels of gonadotrophins in ART may result in disturbances to oocyte growth 
which may increase chances of chromosomal abnormalities or errors in meiosis 
(Hodges et al., 2002). Moreover, FSH levels in women rise with age (Klein et 
al., 1996); therefore, there are concerns that rising FSH levels may contribute 
to the increased levels of aneuploidy seen in older women.   
 
A number of studies in mouse have investigated whether there are changes in 
oocyte chromosomal abnormalities as a result of stimulation with 
gonadotrophins. Early studies reported differing effects on non-disjunction in 
oocytes from stimulated versus unstimulated cycles (reviewed in Santos et al., 
2010); however, a more recent study by Roberts et al. found that mouse oocytes 
exposed to high levels of FSH during in vitro maturation were more likely to 
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undergo aneuploidy at the first meiotic division compared with oocytes treated 
with lower doses of FSH. Moreover, they found that high FSH levels altered 
chromosome congression, with oocytes treated to high doses more likely to 
have chromosomes scattered across the spindle (Roberts et al., 2005). This is 
in keeping with studies from older women who have been shown to have 
oocytes with abnormal spindle morphology (Battaglia et al., 1996). 
 
In humans, high rates of mosaicism have been reported in embryos from IVF 
cycles, which has also led to concerns that ovarian stimulation protocols may 
result in an increase in aneuploidy (Munne et al., 1997). Mosaicism generally 
arises from mitotic, rather than meiotic, segregation errors, leading to genetically 
distinct cell lineages within an individual. To test whether FSH can contribute to 
increased aneuploidy, Baart et al. utilised FISH to study chromosomes in 
blastomeres obtained from a high-dose FSH protocol versus those obtained 
from a low-dose FSH protocol. They found that embryos obtained from the high-
dose protocol were more likely to have aneuploidy, which often arose from 
mitotic segregation errors, leading to mosaicism (Baart et al., 2007). This study 
supports the increasing call for milder ovarian stimulation in IVF cycles, which 
does not appear to increase the rates of chromosomal abnormalities in embryos 
(Labarta et al., 2012). 
 
1.2.4. The origins of aneuploidy 
 
Given the high incidence of aneuploidy in human eggs, the next step was to 
pinpoint the stage at which these errors were prone to arising. This was not 
always straightforward because it soon emerged that different chromosomes 
are associated with different patterns of missegregation. For instance, some of 
the most common trisomies, including 13, 21 and 22 are more likely to arise in 
meiosis I than meiosis II (Yoon et al., 1996, Hall et al., 2007, Hall et al., 2007). 
On the other hand, trisomy 18, one of the few trisomies that is compatible with 
live birth, is more likely to originate at the second meiotic division (Fisher et al., 
1995). Trisomy of chromosome 16 almost always arises during maternal 
meiosis I (Hassold et al., 2007), whereas the additional X chromosome in 
47,XXY has an equal probability of arising paternally or maternally (MacDonald 
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et al., 1994). These differences are believed to arise as a result of differences 
in chromosome architecture. In particular, small acrocentric chromosomes, 
including 13, 14, 15, 21 and 22, appear to be particularly prone to non-
disjunction, which may arise as a result of achiasmate short chromosome arms. 
They are also more likely to have crossovers that are either pericentromeric or 
telomeric, which can increase the chance of non-disjunction, as discussed in 
further detail below. For the majority of these acrocentric chromosomes, non-
disjunction occurs in maternal meiosis I (Zaragoza et al., 1994). Indeed, despite 
these chromosome-specific trends, when taking all chromosomes into account, 
a number of studies found that errors in meiosis I are more prevalent overall 
than errors in meiosis II (Verlinsky et al., 2001, Hassold et al., 2007, Kuliev et 
al., 2011). Given the long gap between initiation and completion of the first 
meiotic division, this is perhaps not surprising. 
 
Although this thesis focuses on meiotic aneuploidy, it is also important to 
mention that there is also a high incidence of mitotic aneuploidy that arises 
during the mitotic divisions of the embryo, often leading to mosaicism 
(Handyside, 1996). As discussed above, it is possible that ovarian stimulation 
protocols contribute to this chromosomal instability. Estimates of mosaicism in 
human embryos derived from IVF vary from 30% to as high as 90%. This 
variability is partly due to fixation techniques such as FISH, variations in clinical 
settings and differing criteria for mosaicism (reviewed in Munne & Wells, 2017). 
Levels of mosaicism for trisomy 21 are estimated to be between 1.3–5% of all 
conceptuses; however, because the phenotype of mosaicism can be mild in 
comparison to having full trisomy 21, it is possible that undetected cases exist 
(Papavassiliou et al., 2015). There is also some evidence of a link between 
maternal age and embryonic mosaicism (Munne et al., 2002), however this 
relationship is debatable and it appears that embryos across all maternal ages 
are prone to a certain level of chromosomal instability (Munne & Wells, 2017). 
 
1.2.5. Mechanisms of missegregation in meiosis I 
 
During the first meiotic division, there are a number of different mechanisms 
through which aneuploidy can arise. This includes: (1) non-disjunction, which 
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involves missegregation of an entire chromosome, (2) premature separation of 
sister chromatids and (3) reverse segregation (see Figure 1.5). Non-disjunction 
was initially identified as the main mechanism of aneuploidy, because prior to 
IVF, early studies focused on chromosomes that led to viable offspring, many 
of which were more likely to undergo non-disjunction. This includes the error-
prone chromosomes 13, 18 and 21 (Hassold et al., 2007). There are two 
different types of non-disjunction: true non-disjunction, in which both 
homologues segregate together, and achiasmate non-disjunction, in which 
homologues that have not recombined travel independently to the same spindle 
pole (Hassold & Hunt, 2001). However, when it became possible to analyse 
leftover oocytes from IVF treatment, researchers began to identify the presence 
of single chromatids (half-chromosomes) in MII oocyte spreads, suggesting that 
non-disjunction was not the main mechanism of aneuploidy in meiosis (Angell, 
1991, Angell, 1997). It soon emerged that premature separation of sister 
chromatids is a more frequent mechanism by which aneuploidy arises in the first 
meiotic division (Pellestor et al., 2002, Gabriel et al., 2011). Premature 
separation can occur when the connections between sister chromatids are lost, 
resulting in gain or loss of a single chromatid.  
 
A limitation of the cytogenetics approaches that have been used to identify 
whole chromosomes and single chromatids in IVF-derived MII oocytes is that 
they cannot pinpoint the precise origin of extra-chromosomal material. Ottolini 
et al. genotyped over 4 million SNPs (single nucleotide polymorphisms) in 
human oocytes and their corresponding first and second polar bodies, which 
enabled precise mapping of crossover locations. Using this approach, they were 
able to identify another type of missegregation at the first meiotic division of 
human oocytes that involves balanced predivision of sister chromatids, or 
reverse segregation. This occurs when a bivalent is converted into two 
univalents (a pair of sister chromatids) which separate at MI, generating an MII 
product that contains two non-sister chromatids (see Figure 1.5d). Although this 
is a balanced division, it can predispose to aneuploidy at the second meiotic 
division if the non-sister chromatids (which are not connected at the 
centromeres) segregate randomly (Ottolini et al., 2015). Direct visualisation of 
this phenomenon has also been observed in live-cell imaging of mouse oocytes 
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Figure 1.5. Mechanisms through which aneuploidy can arise at the first meiotic 
division. Homologous chromosome pairs represented in red and blue, kinetochores in 
orange and centromeric cohesin in green.
Figure 1.5
a
a  Normal MI division
No chiasmata or 
premature loss of 
chiasmata 50% chance of 
gain or loss of 
an entire 
chromosome
b  Non-disjunction
c  Premature separation of sister chromatids
d  Reverse segregation
100% chance 
of gain or loss 
of an entire 
chromosome
50% chance of 
gain or loss of 
a single 
chromatid
Single 
chromatids 
which have a 
50% chance of 
missegregation 
in MII
Failure to resolve 
chiasmata
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as they undergo the first meiotic division, in which predivision of sister 
chromatids accounted for 80% of the errors observed (Sakakibara et al., 2015). 
Although reverse segregation in oocytes has been reported in just two studies 
so far, the data from these studies suggest that it is a frequent occurrence in MI. 
 
These different mechanisms of aneuploidy arise from the unique series of 
events that needs to occur during MI for a successful first meiotic division. This 
includes: resolution of chiasmata formed during the recombination process, 
maintenance of centromeric cohesion, and attachment of sister kinetochores to 
microtubules emanating from the same spindle pole. These features of MI will 
be examined in turn. 
 
1.3. Meiotic recombination and aneuploidy 
  
During meiosis I, homologous chromosomes are tethered together by 
chiasmata formed during recombination. These connections are important 
because they ensure that homologues remain together during the long arrest 
period of the oocyte. A number of early studies into maternal-origin human 
trisomies mapped the inheritance of polymorphic alleles to identify crossover 
locations in the additional chromosome. Study of these trisomies, including 
trisomies 15, 16, 18, 21, Klinefelter (47,XXY) and 47,XXX, identified a clear link 
between reduced recombination in the oocyte and aneuploidy (Lamb et al., 
2005). In many cases, the non-disjoined chromosome was achiasmate, 
meaning that it had not engaged in the recombination process. This absence of 
a physical connection between homologous chromosomes can result in their 
random segregation at the first meiotic division, which can lead to aneuploidy in 
50% of cases if both homologues segregate to the same pole (see Figure 1.5b). 
Small, acrocentric chromosomes in particular, such as chromosome 21, often 
do not have a crossover on the short arm, which may increase their chances of 
non-disjunction (Hassold et al., 2007). Further research into recombination 
involved the genome-wide mapping of recombination foci in fetal oocytes by 
immunostaining with antibodies against MLH1 (mutL homologue 1), a DNA 
mismatch repair protein which localises to sites of recombination in pachytene. 
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This approach revealed a high level of  heterogeneity in the number of MLH1 
foci in fetal oocytes, and frequent observation of achiasmate chromosomes and 
chromosome arms (Tease et al., 2002, Lenzi et al., 2005).  
 
In addition to the number of crossovers, the placement of crossovers also 
appears to affect chances of missegregation in MI. Mapping of crossover 
locations in chromosome 21 in cases of trisomy revealed that crossovers that 
were positioned too near or too far from centromeres were more likely to lead 
to non-disjunction (Lamb et al., 2005) (Lamb 1996). This was corroborated by 
studies in trisomy 16 (Hassold et al., 1995). One mechanism that has been 
proposed to explain this is terminalisation or ‘slippage’ of chiasmata, in which 
crossovers gradually move towards the end of the chromosome where they 
eventually ‘fall off’. Maintenance of chiasmata during the long arrest period 
depends on cohesin, based on data from yeast, Drosophila and mouse 
(Buonomo et al., 2000, Bickel et al., 2002, Hodges et al., 2005), leading to the 
possibility that cohesin loss can cause slippage. Hodges et al. found evidence 
for terminalisation in a mouse model deficient for the SMC1β subunit of cohesin. 
By imaging chromosomes as they underwent the transition from diakinesis (the 
last substage of prophase I) to MI, they were able to visualise chiasmata in 
postnatal oocytes. They found that in mice deficient for SMC1β crossovers were 
located further towards the chromosome ends (Hodges et al., 2005). Cohesin 
along chromosome arms may prevent slippage by acting as a physical barrier 
to chiasmata movement along the chromosomes (Jessberger, 2012). 
 
Since chiasmata are formed in fetal life, the connection between recombination 
and  maternal age-related non-disjunction is not clear. One theory that has been 
proposed to explain this is the production-line hypothesis, which states that the 
first oocytes to enter meiosis in fetal life are the first to be ovulated, and that 
oocytes formed earlier have more recombination foci than ones that form later 
(Henderson & Edwards, 1968). Later oocytes, therefore, are more prone to 
having achiasmate chromosomes which can lead to non-disjunction. Although 
studies in rodents in which germ cells were radiolabelled support the idea that 
oocytes are ovulated in the order in which they were formed (Polani & Crolla, 
1991, Hirshfield, 1992), a comparison of the numbers of recombination foci 
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between early and late human fetal oocytes found no difference in the number 
of crossover sites (Rowsey et al., 2014). Moreover, studies looking at the 
relationship between recombination rates and maternal age have been 
inconclusive, with some reporting a decrease in recombination in older women 
(Hussin et al., 2011, Bleazard et al., 2013), while others have reported no 
difference or an increase (Kong et al., 2004). 
 
A hypothesis that is more commonly cited is the ‘two-hit’ model of aneuploidy 
(Lamb et al., 1996), in which vulnerable crossover configurations constitute the 
first hit and the second hit is an age-related component. 
 
1.4. The role of cohesin during meiosis I 
 
Although non-disjunction is frequently observed amongst particular 
chromosomes, when considering all chromosomes, premature separation of 
sister chromatids is the most common mechanism of aneuploidy. This, in 
addition to the protracted arrest period of the oocyte in which cohesin needs to 
be maintained, has led to a focus on cohesin as the basis for maternal age-
related aneuploidy (Jessberger, 2012). Loss of this centromeric cohesin in 
meiosis I can lead to premature separation of sisters and hence missegregation 
of individual sister chromatids. 
 
1.4.1. Structure of the cohesin complex and its association with DNA 
 
Cohesin belongs to the structural maintenance of chromosomes (SMC) family 
of proteins; the other main member of this family is condensin which confers 
structural rigidity upon chromosomes (Uhlmann, 2016). SMC complexes were 
first identified in a mutant form of Saccharomyces cerevisiae that was unable to 
maintain an artificial centromeric mini-chromosome. The gene responsible, 
called SMC1 (stability of mini-chromosomes), was found to encode an essential 
141 kDa protein that had sequence similarity to genes in both prokaryotes and 
eukaryotes indicating it was highly conserved (Larionov et al., 1985, Strunnikov 
et al., 1993). Although SMC1 appeared to play a role in accurate chromosome 
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segregation, its physiological role was not known until later genetic screens in 
S. cerevisiae identified mutants that were able to separate sister chromatids at 
mitosis in the absence of APC/C activation. Of the six genes responsible for this 
phenotype, four were identified as being part of a core cohesin complex, SMC1, 
SMC3, SCC1 (sister chromatid cohesion) and SCC3, while the remaining two, 
SCC2 and ECO1, were required for cohesin establishment and association with 
chromosomes respectively (Michaelis et al., 1997, Toth et al., 1999). This core 
cohesin complex was found to be highly conserved, from bacteria to eukaryotes 
(reviewed in Wood et al., 2010). 
 
The core cohesin complex consists of four subunits: two SMC subunits, an α-
kleisin subunit and a stromal antigen (STAG) protein. SMCs are large 
polypeptides, made up of between 1000–1300 amino acids. They have globular 
domains at their N- and C- termini which respectively contain the Walker A and 
Walker B nucleotide-binding motifs which are found on almost all nucleotide-
binding proteins (Hirano, 2006). Crystal structure analysis of bacterial and yeast 
SMCs, combined with biochemical and electron microscopy analysis, found that 
the SMC subunits each fold up to form rod-shaped structures which comprise 
globular domains at either end that are linked by a 45 nm antiparallel coiled-coil 
(see Figure 1.6a). This distance is equivalent to approximately 150 bp of DNA 
(Hirano, 2006), and is larger than the width of a chromatin fibre which is 
approximately 30 nm (Li & Zhu, 2015). When the structure folds up, it unites the 
ATP-binding Walker A motif on the N-terminus with the Walker B motif on the 
C-terminus to form a functional ATPase (Haering et al., 2002). The other 
globular domain forms the ‘hinge’ domain of the protein; measurement of the 
hinge angle by EM has found it to be approximately 88 degrees (Anderson et 
al., 2002). The hinge domains of Smc1 and Smc3 interact with each other, 
forming a V-shaped Smc1/3 heterodimer (Haering et al., 2002). The nuclear-
binding domains (NBDs) of SMC proteins interact with another family of proteins 
known as kleisins. There are four major classes of kleisins (α, β, γ, and δ), of 
which α-kleisins are present in all eukaryotes and are essential for cohesin 
function (Nasmyth & Haering, 2005). In eukaryotes, The NBDs of Smc1 and 
Smc3 bind the N and C terminus of the α-kleisin SCC1 respectively, forming a 
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tripartite ring structure. The kleisin component then recruits Scc3 (or STAG3 in 
humans) and completes the complex (Figure 1.6a). 
 
Given the molecular architecture of the cohesin complex, it has been proposed 
that cohesin mediates sister chromatid cohesion by trapping DNA duplexes 
within its ring structure. Support for a topological link between cohesin rings and 
DNA comes from the fact that cleavage of Scc1 or the Smc3 coiled-coil results 
in its disassociation of the complex from DNA (Gruber et al., 2003). In addition, 
the SMC heterodimer is highly flexible, with a range of conformations observed 
in the bacterial forms of the protein under electron microscopy (Melby et al., 
1998). Opening and closing of the ring is controlled by ATP binding at the NBD 
domains: ATP binding causes the NBDs of the SMC subunits to associate with 
each other, thus closing the ring, and ATP hydrolysis results in disassociation 
(Shintomi & Hirano, 2007). In this way, the SMC heterodimer is though to act as 
a gate for DNA that can open and close in a highly regulated fashion. Two 
different models for the cohesin ring structure have been proposed: the strong 
ring model, in which two DNA duplexes are captured within the coiled-coil region 
of the SMC complex (Haering et al., 2002), and the weak ring model, in which 
two cohesin rings each capture a single DNA duplex and are linked together in 
some way, forming a handcuff-like structure (see Figure 1.6b-c). There is little 
evidence that multimeric forms of cohesin exist, suggesting that the strong ring 
model is a more likely possibility (Nasmyth & Haering, 2009). 
 
1.4.2. Cohesin localisation 
 
In S. pombe and S. cerevisiae, cohesin has been shown to localise to regions 
of heterochromatin, which appears to be specifically required for cohesin 
recruitment (Bernard et al., 2001, Chang et al., 2005). Heterochromatin is highly 
dense, transcriptionally silent DNA, characterised by methylation of lysine 9 on 
histone H3 (H3K9me), and is found at centromeres and telomeres throughout 
the cell cycle. Other regions of the genome also remodel DNA into 
heterochromatin in response to cellular signals or gene activity, where it is 
known as facultative heterochromatin (Grewal & Jia, 2007). The 
pericentromere, the region surrounding the centromere, is where cohesin is 
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Figure 1.6. Structure of meiotic cohesin. (a) Structure of the cohesin complex. Meiotic 
cohesin is made up of two structural maintenance of chromosomes (SMC) family proteins, 
shown here in blue and purple, each of which fold up to form a structure that contains two 
globular domains connected by a 45 bp coiled-coil. The two SMC subunits form a V-shaped 
complex with a hinge domain at one end and an ATP-binding domain at the other end 
containing the Walker A and B motifs. Rec8 (green) binds to this region and closes the ring.  
It also recruits the final cohesin component, Stag3. (b) Strong ring model of cohesin in which 
two sister chromatids (grey) are trapped within the ring structure. (c) Weak ring model, in 
which linked cohesin rings each trap a single sister chromatid. Shown here is just one of the 
proposed models for a weak ring structure. Adapted from Hirano (2006) and Nasmyth & 
Haering (2009).
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most concentrated. Centromeres are regions of heterochromatin characterised 
by the presence of a histone 3 variant, centromeric protein A (CENP-A), and 
enriched in cohesins, condensins and topoisomerase II (Bloom, 2014). In 
addition to acting as a site for kinetochore formation, the heterochromatic 
architecture of the centromere also dictates the geometry and function of 
kinetochore and the spindle (Verdaasdonk & Bloom, 2011). In budding yeast, 
which have short 125 bp ‘point’ centromeres that form attachments to a single 
microtubule, cohesin is enriched by about threefold in the 30–50 Kb region 
surrounding the centromere (Weber et al., 2004, Bloom, 2014). Cohesin 
appears to play an important role in maintaining chromatin architecture at the 
centromeres, as a reduction in centromeric cohesin in budding yeast causes 
increased centromere stretching and increased chromosome missegregation 
(Eckert et al., 2007). Unlike yeast, mammals have larger and more complex 
regional centromeres composed of highly repetitive DNA sequences. In 
humans, they can be up to 5 Mb and contain anywhere between 1–4 Mb of 171-
bp α-satellite repeats (Verdaasdonk & Bloom, 2011). The repetitive sequences 
of mammalian centromeres preclude genome-wide mapping based approaches 
to measure centromeric cohesin levels, but immunofluorescent staining has 
shown that cohesin is also enriched in centromeric regions in human mitotic 
cells (Hoque & Ishikawa, 2001).  
 
In addition to the centromeric localisation of cohesin, genome-wide mapping of 
cohesin in yeast has also shown that the position of cohesin on chromosomes 
changes with transcriptional activity, with cohesins enriched at 3’ ends of genes 
and in the intergenic regions of genes that are transcribed in converging 
directions (Lengronne et al., 2004). In mammals, on the other hand, cohesin 
along chromosome arms appears to be equally distributed between genic and 
intergenic regions, with its positioning dependent on the underlying DNA 
sequence; in particular, it is enriched at binding sites for the DNA-binding protein 
CTCF (Parelho et al., 2008). The average spacing distance between cohesin 
molecules in mammalian chromosomes has been measured to be 22.2 Kb, 
although its positioning along chromosomes is irregular (Parelho et al., 2008). 
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1.4.3. Differences between mitotic and meiotic cohesin 
 
There are some differences between mitotic and meiotic cohesin, which reflect 
the different roles that cohesin plays in each of these divisions; namely, that in 
meiosis, cohesin is protected at centromeres during the first meiotic division. In 
mitosis, the human cohesin complex is made up of SMC1α, SMC3, the α-kleisin 
RAD21 and STAG1/2. In meiosis, SMC1α, RAD21 and STAG1/2 are replaced 
respectively with the meiosis-specific components SMC1β, REC8 and STAG3 
(Nasmyth & Haering, 2009). The meiotic structure of cohesin is similar to that of 
mitotic cohesin: the SMC subunits form a V-shaped structure that is bridged by 
the α-kleisin Rec8 to form a ring (Revenkova et al., 2004, Nasmyth & Haering, 
2009, Jessberger, 2012), and STAG3 associates with Rec8 and completes the 
complex (Revenkova & Jessberger, 2005). Although the molecular structure of 
the complex is the same, the different cohesin components have meiosis-
specific roles. For instance, the meiosis-specific α-kleisin Rec8 appears to be 
essential for the reductional division in meiosis I, because deletion of the Rec8 
gene in S. pombe causes sister chromatids to separate at meiosis I (Watanabe 
& Nurse, 1999). STAG3, the meiotic equivalent of STAG 1/2, is involved in sister 
chromatid arm cohesion as it comprises the axial/lateral elements of the 
synaptonemal complex (Pezzi et al., 2000, Prieto et al., 2001). Loss of STAG3 
in mice results in sterility due to failure of homologous chromosomes to synapse 
as a result of incomplete assembly of synaptonemal complex axial elements 
(Winters et al., 2014). 
 
1.4.4. Mechanisms of cohesin dissociation from chromosomes 
 
In vertebrates, cohesin is removed from chromosome arms by two separate 
pathways, which are characterised by different temporal regulation and 
mechanisms. The first removal pathway occurs between prophase and 
prometaphase, and removes most arm cohesin in a process that is dependent 
on a chromosome-associated protein known as Wapl (Gandhi et al., 2006, 
Kueng et al., 2006). The second mechanism of cohesin removal is via 
proteolytic cleavage of the kleisin subunit of cohesin by a protein called 
separase (Buonomo et al., 2000, Hauf et al., 2001, Kitajima et al., 2003). 
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 At centromeres, cohesin is protected from removal by the prophase pathway by 
a protein called shugoshin 1 (Sgo1) which acts together with protein 
phosphatase 2A (PP2A) to protect cohesin (Watanabe & Kitajima, 2005, 
Nasmyth & Haering, 2009). Purified Sgo complex can dephosphorylate of 
cohesin in vitro suggesting that the mechanism of cohesin protection is likely to 
involve dephosphorylation (Kitajima et al., 2006). In mouse oocytes, Sgo2 is 
required for centromeric Rec8 protection: loss of Sgo results in centromeric 
cohesin removal during meiosis I, indicating its role as a meiosis-specific 
coordinator of centromeric protection (Lee et al., 2008, Llano et al., 2008). 
 
1.4.5. Is there turnover of cohesin during meiotic prophase I arrest? 
 
In mammalian meiosis, including humans and mice, cohesin is loaded onto 
chromosome arms early in first meiotic prophase, which occurs during fetal life 
(Garcia-Cruz et al., 2010, Kuleszewicz et al., 2013). The first meiotic division is 
completed shortly before ovulation, so cohesin is required to keep 
chromosomes together for several months in mice and many years in humans. 
This raises the question of whether there is turnover of cohesin subunits during 
the long period of prophase arrest. 
 
Work in mouse oocytes has indicated that there is no cohesin turnover during 
the arrest period. In the first of these studies, the SMC1β gene was inactivated 
in mice shortly after birth using Cre-mediated recombination, preventing 
synthesis of new cohesin transcripts. The treated mice retained full fertility, and 
chiasmata position and number in their oocytes appeared normal, which 
indicates that expression of cohesin is not required during prophase I arrest in 
mouse (Revenkova et al., 2010). This does not, however, exclude the possibility 
that new cohesin is synthesised from pre-existing mRNA or is reloaded onto 
chromosomes from existing pools of protein in the cell. A further study by 
Tachibana-Konwalski et al. created mice with a cleavable form of the Rec8 
protein by incorporating a TEV site into the protein. This enabled cohesin 
inactivation in oocytes after birth through TEV protease treatment. As might be 
expected, Rec8 cleavage resulted in conversion of bivalents to univalents and 
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then to single chromatids. Activation of a transgene, driven by a Zp3 (zona 
pellucida 3) promoter which is only activated during oocyte growth, encoding 
non-cleavable Rec8 did not prevent the conversion of bivalents into chromatids, 
indicating that newly-synthesised Rec8 was not loaded onto chromosomes 
during the period of oocyte growth (Tachibana-Konwalski et al., 2010). 
However, as the transgene was only expressed during oocyte growth there is 
still the possibility that turnover occurs later in development. Building on this 
work, a further study used tamoxifen-induced activation of a transgene for non-
cleavable Rec8 in the same mouse model, enabling the researchers to test 
whether there was cohesin reloading over a period of months. As in the earlier 
study, protease treatment resulted in bivalent conversion to chromatids, despite 
activation of the transgene over a period of 2 or 4 months (Burkhardt et al., 
2016). Hence, results from mouse oocytes indicate that there is no cohesin 
turnover during the prophase arrest period of the oocyte. 
 
1.4.6. The relationship between cohesin levels and age 
 
Given the apparent lack of cohesin turnover, the next important question to ask 
is whether there is a deterioration in cohesin levels over time. A study conducted 
in a naturally-ageing mouse strain treated MI-stage oocytes with monastrol, a 
kinesin-5 inhibitor (Mayer et al., 1999), to create monopolar spindles, then 
generated chromosome spreads from these eggs. Treatment with kinesin-5 
minimises the pulling forces generated on sister kinetochores by microtubules, 
meaning any inter-kinetochore distance reflects the amount of centromeric 
cohesin. They found that the distance between sister chromatid kinetochores 
increases with age, indicating a decline in cohesin; importantly, this distance 
was found to be increased in aneuploid eggs (Chiang et al., 2010). Another 
study stained Rec8 in mouse oocyte spreads and showed that Rec8 abundance 
was reduced in spreads from older mice (Lister et al., 2010). Using the same 
approach, the researchers also identified a concomitant decline in levels of 
Sgo2, which protects Rec8 from cleavage by separase (Lee et al., 2008). An 
age-dependent decline in Sgo2 could therefore also contribute to the maternal 
age effect. Another study measured Rec8, STAG3 and SMC1b levels in 
senescence-accelerated mice  that have been used in aging studies, and found 
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that levels were markedly reduced in oocytes from these strains (Liu & Keefe, 
2008), There is therefore evidence from mouse that cohesin declines with age 
and is a likely contributor to aneuploidy in older oocytes. 
 
Given the difficulty of obtaining human oocytes for research purposes, relatively 
few studies on cohesin decline have been conducted in humans. Duncan et al. 
measured inter-kinetochore distances in 18 MII oocytes from 6 women aged 
between 16 and 37 years who had their ovaries removed for medical 
indications, with the aim of identifying whether there was a decline in cohesin 
with age. The oocytes were isolated and matured in vitro, then treated with 
monastrol, an inhibitor of the Eg5 kinesin, to generate monopolar spindles, 
which limits the effect of pulling forces from spindle kinetochore-fibres which can 
alter inter-kinetochore distance. After fixation and immunostaining of 
kinetochores using CREST antisera, they measured inter-kinetochore distance 
and found that it was greater in the oocytes from older patients, suggesting a 
decline in centromeric cohesin (Duncan et al., 2012). However, as most of the 
women in the study had cancer the possibility that the oocytes had undergone 
chromosomal deterioration or molecular damage cannot be ruled out. 
Furthermore, the study only includes women up to the age of 37 years, which 
means they had no women in their late 30s/early 40s when the aneuploidy risk 
becomes significant. Another study in humans used immunofluorescence to 
measure the relative intensities of Rec8 and Smc1β levels in oocytes in adult 
ovarian tissue sections from eight women with ovarian tumours. They showed 
that cohesin formed thread-like patterns (comparable to fetal oocytes) and 
identified a decline in levels of Rec8 and Smc1β between older and younger 
women (Tsutsumi et al., 2014). However, the study quantified cohesin in thin 
tissue sections, which does not give a full picture of cohesin in individual 
oocytes. Moreover, as the material for this work came from women with ovarian 
tumours, this raises concerns about sample quality. 
 
Therefore, there are indications that cohesin declines with age in humans, 
however as the research performed so far has been on samples obtained from 
women with cancer or ovarian tumours, the data from human studies should be 
treated with caution. Given the limited amount of research conducted on 
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cohesin in human samples, further work is needed to determine whether 
cohesin decline contributes to aneuploidy in humans. 
 
1.5. Kinetochores in the first meiotic division 
 
During the first meiotic division, protection of centromeric cohesin is important 
for keeping sister chromatids together, but it may also help to ensure that 
kinetochores on sister chromatids form attachments to the same spindle pole. 
Kinetochores are multiprotein assemblies that constitute the physical interface 
between the chromosome and the spindle. As well as acting as a mechanical 
link between chromosomes and spindle microtubule fibres, they are also a 
signalling platform for spindle checkpoint proteins that control entry into 
anaphase (Musacchio & Salmon, 2007). Accurate chromosome segregation, in 
both mitosis and meiosis, depends on the formation of stable kinetochore-
microtubule attachments and correction of any erroneous attachments. 
 
1.5.1. Kinetochore structure and function 
 
Kinetochores are disk-shaped structures, consisting of three distinct layers 
when examined by electron microscopy (Jokelainen, 1967; Comings and 
Okada, 1971): the inner plate, outer plate and fibrous corona (Chan et al., 2005). 
Kinetochores assemble on centromeres, regions of specialised DNA, 
characterised by the presence of the histone 3 variant CENP-A which 
assembles into specialised nucleosomes (Sullivan & Karpen, 2004). Although 
centromeres vary in size between species, from the point centromeres of S. 
cerevisiae to the large regional centromeres found in mammals, the CENP-A 
protein is highly conserved, and loss of it is lethal in every organism studied to 
date (McKinley & Cheeseman, 2016). The timing of CENP-A incorporation into 
centromeric nucleosomes varies between species, but in humans it occurs 
between anaphase and G1 of the cell cycle. The geometry of centromeric 
chromatin is thought be such that the CENP-A containing nucleosomes are 
exposed to the spindle poles, whilst H3 nucleosomes are found within the inner 
chromatid region (Sullivan & Karpen, 2004, Verdaasdonk & Bloom, 2011, 
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Schalch & Steiner, 2017). This gives rise to the mitotic ‘back-to-back’ 
arrangement of sister kinetochores which can facilitate amphitelic attachment in 
mitosis. Inner centromeric components and kinetochores are interlinked, as we 
shall see. 
 
The kinetochore inner plate consists of a number of components that make up 
the constitutive centromere-associated network (CCAN), which provides 
structural integrity and acts as a platform for subsequent loading of outer 
kinetochore proteins (Suzuki et al., 2014). CENP-A is an important component 
of the CCAN, already discussed. Of the other components that constitute the 
CCAN, CENP-C and CENP-T, interact with the highly-conserved KMN network 
of outer kinetochore components that forms attachments to microtubules (Foley 
& Kapoor, 2013). The KMN network consists of three complexes, Knl1, Mis12 
and Ndc80, and forms the interface between centromeric DNA and microtubule 
attachment. Specifically, the four-subunit Ndc80 complex (made up of 
hNdc80/Hec1, Nuf2, Spc24 and Spc25) forms attachments to microtubule plus-
ends, which are strengthened by Knl1. Phosphorylation of Ndc80/Hec1 by 
Aurora B kinase regulates attachment status (Cheeseman et al., 2006). The 
Mis12 component of KMN links the complex with CENP-C. These connections 
enable inner kinetochore stretching to link with stabilisation of microtubule 
attachments. The outermost region of the kinetochore, the fibrous corona, 
comprises components of the kinetochore that are more transiently linked to the 
kinetochore and include spindle assembly checkpoint and motor proteins. This 
includes the microtubule plus-end-directed motor protein CENP-E, which is 
essential during mitosis for transporting misaligned chromosomes towards the 
cell equator and for stabilising kinetochore-microtubule attachments (Kapoor et 
al., 2006, Gudimchuk et al., 2013). 
 
In mitosis, during the process of chromosome alignment at the metaphase plate, 
inter-kinetochore distance is not fixed, and the linkages between sisters stretch 
in response to chromosome oscillations, a behaviour referred to as ‘breathing’ 
(Skibbens et al., 1993). Oscillations are linked to chromosome congression, as 
a reduction in oscillation speed results in a thinner metaphase plate, indicating 
that chromosomes have become aligned (Jaqaman et al., 2010). Oscillations 
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appear to depend on the stiffness of the mechanical linkages between sister 
kinetochores which are mediated by cohesin (Nasmyth, 2002) and condensin 
(Ono et al., 2004, Oliveira et al., 2005, Hirano, 2012). Condensin subunit 
depletion, resulting in a less stiff linkage, increases oscillation speed and 
periodicity, whilst increased stiffness, achieved through separase depletion, had 
the opposite effect (Jaqaman et al., 2010). These results indicate that 
centromeric stiffness play a role in regulating chromosome oscillations and 
hence chromosome congression at the metaphase plate. 
 
In addition to inter-kinetochore distance, intra-kinetochore distances during 
mitosis are also not fixed. The relative positions of certain components that 
make up the inner plate, outer plate and fibrous corona change during 
metaphase when chromosomes are aligning. This stretching is thought to be 
important for satisfying the spindle assembly checkpoint, particularly as loss of 
stretch results in checkpoint activation (Maresca & Salmon, 2009). The degree 
of stretch and identification of compliant regions can be determined by 
measuring the distances between different inner and outer components. For 
instance, using two-colour immunofluorescence in fixed HeLa cells in 
metaphase, Wan et al. measured the distance between antibody-tagged 
kinetochore proteins to an accuracy of <5 nm. Using this approach, it was 
possible to build up a nanoscale map of kinetochore architecture, which 
revealed that most compliancy is within the inner region of the kinetochore that 
interacts with centromeric chromatin (Wan et al., 2009). Further work by Suzuki 
et al. used this method to investigate the architecture of the CCAN. They found 
that depletion of CCAN components resulted in hyperstretching of the inner 
kinetochore, which in turn led to decreased Ndc80/Hec1 phosphorylation, 
indicating that inner kinetochore stretch is closely linked to regulation of 
kinetochore-microtubule attachments (Suzuki et al., 2014).  
 
1.5.2. Kinetochore-microtubule attachment stability in MI 
 
Studies looking at kinetochore architecture have so far been limited to mitosis, 
in which sister kinetochores form attachments to microtubule kinetochore-fibres 
(k-fibres) from opposite spindle poles. During the first meiotic division, however, 
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the opposite is true: sisters form attachments to k-fibres from the same spindle 
pole. There is evidence that formation of k-fibre attachments in oocytes during 
MI is impaired. Immunofluorescence analysis of mouse oocytes, fixed at various 
timepoints after nuclear envelope breakdown, found that they are prone to 
forming incorrect attachments, such as merotelic attachments (in which 
kinetochores are attached to microtubule fibres from both poles). Like in mitosis, 
correction of these attachments is dependent on the activity of Aurora B kinase 
(Kitajima et al., 2011). There are also indications that formation of stable 
attachments is related to age. Shomper et al. compared kinetochore-
microtubule attachments in fixed oocytes from young and aged mice, and found 
that oocytes from older mice have a higher proportion of incorrect attachments 
than those from younger mice (Shomper et al., 2014). This propensity to form 
incorrect attachments also appears to apply to human oocytes. Live-cell 
imaging in human oocytes after GV breakdown found that the prolonged spindle 
assembly period of ~16 hours was accompanied by a high proportion of 
erroneous kinetochore-microtubule attachments (Holubcova et al., 2015). It is 
not clear why attachment is so error-prone in MI, but one possibility may be the 
altered sister kinetochore geometry that enables sisters to attach to k-fibres from 
the same pole. 
 
1.5.3. Kinetochore geometry during the first meiotic division 
 
The first meiotic division represents a unique situation for sister kinetochores 
because sister chromatids must segregate together, so the mitotic back-to-back 
arrangement is no longer appropriate. Electron microscopy in mouse 
spermatocytes has provided support for a ‘side-by-side’ arrangement of sister 
kinetochores in meiosis I bivalents (Parra et al., 2004), a configuration that 
would enable co-segregation of sister chromatids. This altered arrangement has 
implications for the geometry and internal architecture of the meiotic kinetochore 
(Figure 1.7). I examine here what is known about sister kinetochore geometry 
during MI. 
 
Most studies have indicated that fusion of sisters is the main mechanism of 
ensuring co-segregation of sisters in MI. A functional genomics screen in 
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Figure 1.7. Kinetochore orientation in mitosis and meiosis I. (a) In mitosis, kinetochores 
are in a back-to-back arrangement, with the outer regions of each kinetochore (orange) facing 
opposite spindle poles. (b) In meiosis I, however, sister kinetochores are in a side-by-side 
arrangement with their outer regions facing the same spindle pole. In both cases, the inner 
plate of the kinetochore (green) faces inwards towards the centromeric chromatin.
a b
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budding yeast identified the kinetochore-localised Mam1 protein as being 
crucial for homologue segregation in MI by promoting attachment of sister 
kinetochores to microtubules from the same spindle pole (Toth et al., 2000). 
Further work identified three other proteins, Csm1, Lrs4 and Hrr25, that act in 
complex with Mam1 to ensure homologue separation (Rabitsch et al., 2003, 
Petronczki et al., 2006). Collectively, these proteins are known as the monopolin 
complex as they are required for sister kinetochore monopolar attachment 
(attachment to one spindle pole). It is likely that monopolin induces a physical 
linkage between sister kinetochores, because expressing monopolin 
components in mitotic yeast cells results in mono-orientation of sister 
kinetochores (Monje-Casas et al., 2007). Crystal structure analysis revealed 
that monopolin forms a V-shaped complex that may enable it to directly crosslink 
sisters (Corbett et al., 2010).  
 
An alternative model for sister kinetochore arrangement in MI is one in which 
one sister is selectively inactivated or ‘shut off’. Electron micrographs of 
kinetochore-microtubule attachments in budding yeast MI cells revealed that 
fused sister kinetochores form a single kinetochore-fibre attachment, like in 
mitosis (Winey et al., 2005). This may indicate that sisters fused by monopolin 
behave as a single functional unit; however an alternative explanation for this 
could be selective inactivation of a kinetochore within the pair. To address 
whether kinetochore inactivation occurs in yeast, Sarangapani et al. isolated 
fused sister kinetochores from MI yeast cells and found that, compared to their 
mitotic counterparts, they have more microtubule-binding elements and form 
stronger attachments, indicating that both sister kinetochores contribute to k-
fibre attachment formation (Sarangapani et al., 2014). It therefore appears that 
in yeast, fused kinetochores act as a co-functional unit to ensure homologue 
segregation in MI. 
 
There does not appear to be conservation of mono-orientation between different 
yeast species, as orthologues of monopolin have not been identified in other 
species. In fission yeast, homologue segregation is instead promoted in a 
cohesin-dependent manner by the kinetochore protein Moa1 (Yokobayashi & 
Watanabe, 2005). Moa1 does not share homology with any of the proteins 
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required for mono-orientation in budding yeast, indicating significant divergence 
in the proteins involved in monopolar attachment. Moa1 is recruited to the 
centromere by the inner kinetochore protein Cnp3 (Tanaka et al., 2009), a 
homologue of CCAN component CENP-C, where it induces sister kinetochore 
mono-orientation through direct interaction with Rec8. In the absence of 
centromeric Rec8, Moa1 is unable to establish mono-orientation, indicating that 
cohesin is an essential component in fission yeast mono-orientation 
(Yokobayashi & Watanabe, 2005). Although cohesin is not needed in budding 
yeast for mono-orientation, another complex containing components of the 
SMC (structural maintenance of chromosomes) family, condensin, is important; 
without it, there is an increase in the numbers of bi-oriented sister kinetochores 
during MI and a decrease in Mam1 association with kinetochores (Brito et al., 
2010). 
 
In mouse, a yeast two-hybrid screen for CENP-C interactors during meiosis in 
testis samples identified Meikin, which localises to kinetochores during MI in 
mouse spermatozoa and oocytes. In Meikin-deficient mouse oocytes, sister 
kinetochores in MI appear as two spots under light microscopy, rather than a 
single spot, indicating loss of fusion. Like in fission yeast, there appears to be a 
role for Rec8 in mouse MI, because in Meikin-deficient oocytes, the cohesin 
complex component Rec8 is lost at the centromere in metaphase II 
chromosomes (Kim et al., 2015). A separate study in mouse oocytes found that 
selective cleavage of Rec8 at the centromeres resulted in sister kinetochore 
splitting, supporting its role in mono-orientation (Tachibana-Konwalski et al., 
2013). 
 
An alternative model of sister kinetochore arrangement in MI comes from plants. 
In maize MI, the inner kinetochore is separated, but the outer kinetochore 
components Mis12 and Ndc80 (part of the KMN complex) form a bridge 
structure linking the two sister kinetochores, which can be visualised using 
immunofluorescence microscopy. As the outer plate is involved in formation of 
stable k-fibre attachments, this model would enable sisters to form a single k-
fibre attachment between them to ensure co-segregation. Depletion of Mis12 
causes breaking of the bridge structure and random attachment of sister 
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kinetochores, resulting in subsequent failure to complete anaphase (Li & Dawe, 
2009). 
 
Thus, there are a number of mechanisms in which sister kinetochores can be 
arranged to achieve the first meiotic division. All of the mechanisms described 
involve some form of physical association between the two sisters, whether it is 
linkage by a regulator such as monopolin or Meikin, or direct linkage of 
kinetochore components as in plants. Although a homologue of Meikin exists in 
humans, its presence in human oocytes has not been observed, and the 
geometry of the human oocyte kinetochore remains uncharacterised. 
 
1.6. Aim of this project  
 
An understanding of meiotic kinetochore arrangement in human oocytes may 
help us to understand why the first meiotic division is highly error-prone. To 
characterise the geometry and organisation of kinetochores in the first meiotic 
division of human oocytes, I aimed to fix intact human MI oocytes and study 
their chromosomes and kinetochores at high-resolution using spinning-disk 
confocal microscopy. Immunofluorescence will be used to visualise 
chromosomes and kinetochores in these oocytes, using different markers of 
kinetochore proteins to build up a picture of internal kinetochore architecture. 
The advantage of fixing oocytes intact is that this will enable study of 
kinetochore arrangement within bivalents in situ, as previous approaches that 
have used chromosome spreading result in loss of spatial information of 
kinetochore arrangement. A particular area of focus in my research into the 
human female meiotic kinetochore will be to determine whether there are any 
age-associated changes in organisation. I aim to follow up meiotic kinetochore 
characterisation with establishing a live-cell imaging platform for studying 
kinetochore dynamics during the first meiotic division. 
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Chapter 2: Materials and Methods 
 
2.1. Human oocytes 
 
2.1.1. Donation of oocytes to research 
 
Oocytes used in this study were donated by patients undergoing in vitro 
fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) at the Centre for 
Reproductive Medicine, University Hospitals Coventry & Warwickshire. Table 
2.1 gives details of the oocytes and patients used in the study. Informed consent 
for donation of oocytes to research was obtained from all patients whose 
oocytes were used. Approval for this research was granted by the NHS 
Research Ethics Committee and the Human Fertilisation and Embryology 
Authority (HFEA; research licence RO155). See Appendix C for copies of 
HFEA licences and documentation pertaining to acquisition of patient consent. 
All oocytes donated to research were unsuitable for use in the donating patient’s 
treatment and would otherwise have been discarded. Unsuitable oocytes 
obtained from IVF patients were those that had been incubated with sperm 
overnight, but showed no indications of having been fertilised. From ICSI 
patients, unsuitable oocytes were those that had been assessed as being at 
germinal vesicle (GV) or metaphase I (MI) stage, by light microscopy prior to 
sperm microinjection. The decision as to which oocytes were suitable for 
research use, checking of consent, and witnessing of their removal from the 
clinical pathway, was undertaken by clinical embryologists. For purposes of 
selection for research use, oocytes were presumed to be in metaphase I (MI) if 
neither a germinal vesicle (GV) nucleus nor polar bodies were visible by light 
microscopy. This initial clinical assessment was further informed by detailed 
analysis of chromosomes in the course of the research. 
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2.1.2. Ovarian stimulation 
 
All women who received IVF/ICSI treatment first underwent a period of ovarian 
stimulation through one of two protocols, administered under the guidance of 
medical personnel. In the ‘long’ protocol, a gonadotrophin-releasing hormone 
(GnRH) agonist was administered to achieve pituitary suppression, which was 
then followed by a period of exogenous FSH administration. In the antagonist 
(or short) protocol, a GnRH antagonist was administered which competitively 
binds to FSH receptors, thus requiring a shorter period of treatment and 
generally lower doses of FSH. For the patients included in the study, daily 
gonadotrophin doses varied from 150–450 i.u. (Table 2.1). There did not appear 
to be a relationship between the total FSH dose received by women and the 
proportion of distinct kinetochore pairs or inter-kinetochore distance (Figure 
2.1). 
 
2.1.3. Whole oocyte fixation 
 
Fixation and staining of human oocytes was performed using an adapted 
version of a previously published protocol (Riris et al., 2013). Upon allocation to 
research, oocytes were washed briefly in PHEM buffer (60 mM PIPES, 25 mM 
HEPES, 10 mM EGTA, 4 mM MgSO4.7H2O; pH 6.9) with 0.25% Triton X-100 
at 37°C to stabilise microtubules and permeabilise the cell membrane. They 
were then fixed in 3.7% paraformaldehyde in PHEM for 30 min at room 
temperature. Following fixation, oocytes were placed in PBB (0.5% BSA in PBS) 
for 5 min, then permeabilised with 0.25% Triton X-100 in PBS for 15 min. To 
prevent non-specific antibody binding they were then transferred to a blocking 
solution (3% BSA in PBS with 0.05% Tween-20) where they were stored at 4°C 
overnight. For cold shock treatment, oocytes were placed in ice-cold media for 
2 min upon receipt, then fixation was performed as described. All fixation steps 
were performed in 4-well IVF plates (Nunc). 
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Table 2.1. Details of the women donating oocytes to this study, including reasons for 
assisted reproductive treatment, stimulation data and outcomes. Patients 2, 5, 6, 7, 9, 
10, 11, 12, 14 and 16 have demonstrated fertility by becoming pregnant either as a result of 
treatment or previously. Patients underwent one of two stimulation protocols, described in 
more detail in the Materials and Methods section. Briefly, the ‘long’ protocol involves pituitary 
suppression with GnRH agonists over several weeks to prevent a surge in luteinising 
hormone (LH). The ‘antagonist’ protocol involves treatment with gonadotrophin-releasing 
hormone (GnRH) antagonists which competitively bind to pituitary GnRH receptors, resulting 
in rapid inhibition of gonadotrophin release. This avoids the long down-regulation period 
involved in the long protocol and is often used in women where there is a risk of ovarian 
hyperstimulation syndrome. Asterisks indicate women with no known fertility issues, whose 
partner’s infertility or absence of a male partner may explain the couple’s infertility. Parity 
data is shown as parity (number of births >24 weeks) + gravidity (number of pregnancies). 
FH: fetal heart visible on ultrasound scan. IVF: in vitro fertilisation. ICSI: intracytoplasmic 
sperm injection. Neg: no pregnancy. †Patient was undergoing IVF for surrogacy, due to 
cardiomyopathy.
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Figure 2.1. Examination of the effect of total follicle-stimulating hormone (FSH) dose  
on the results reported in this thesis. Women included in this study received daily 
exogenous FSH in varying doses for between 8–14 days prior to oocyte collection. (a) There 
does not appear to be a correlation between FSH dose and the proportion of distinct sister 
kinetochore pairs (sister kinetochores that appear as two distinct foci under high-resolution 
immunofluorescent imaging) per oocyte. Pearson’s R = 0.111. (b) There is weak correlation 
between FSH dose and inter-kinetochore distance. Pearson’s R = 0.415.
Figure 2.1
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2.1.4. Immunofluorescence of fixed human oocytes 
 
Fixed oocytes were incubated at 37°C for 1 hr in 20 µl droplets of blocking 
solution containing primary antibodies at the relevant dilution (see Table 2.2). 
The droplets were placed in 4-well IVF dishes and were overlaid with sterile 
mineral oil (Sigma) to prevent evaporation of the blocking solution. Oocytes from 
different patients were processed separately. Oocytes from the same patient 
were stained in batches only if they were to be stained with the same 
combination of primary antibodies. Incubation with primary antibodies was 
followed by a 15 min wash at room temperature in PBB with 0.05% Tween-20. 
This was followed by 1 hr incubation with secondary antibodies at 37°C, 
followed by a final wash. Oocytes were mounted in a 5 µl droplet of ProLong® 
Gold Antifade Mountant with DAPI (Invitrogen) mixed 1:1 with blocking solution 
in 35 mm dishes with No. 0 coverglass bottoms (MatTek). After transferral into 
mountant, oocytes were left overnight where they settled naturally towards the 
base of the dish. After mounting, oocytes were stored at 4ºC. 
 
2.1.5. Oocytes included in the study 
 
In total, 216 oocytes from 81 patients underwent fixation, immunofluorescence 
and high-resolution imaging, as described above. Of these, 119 (from 58 
patients) were classified as ‘immature’ by embryologists upon donation (i.e. GV 
or MI stage). Although the aim of this research was to study MI oocytes, GV 
stage oocytes were also fixed because there was the possibility that they would 
have advanced to MI by the time of fixation. Upon high-resolution imaging, only 
a small fraction of the oocytes classified as immature (27/119, from 20 patients) 
were found to be in MI and therefore were suitable for analysis of kinetochores 
at the first meiotic division. Oocytes were excluded if they contained a GV (n = 
12), had advanced to MII (n = 37), were in telophase (n = 2) or contained 
abnormalities that made them unsuitable for analysis (n = 41). Common 
abnormalities included: presence of multiple spindles, abnormal chromosome 
appearance, chromosomes scattered throughout oocyte cytoplasm. See 
Figure 2.2 for examples of oocytes that were excluded. In addition, 97 MII stage 
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Table 2.2. 
 
Antibody Type Dilution Source 
CREST antisera 1º 1:50 Antibodies Incorporated 
Rabbit CENP-E 1º 1:200 Meraldi et al. (2004) 
Mouse monoclonal a-tubulin 1º 1:200 Sigma (T6074) 
Mouse monoclonal against Hec1-9G3 1º 1:50 Abcam (ab3613) 
Mouse monoclonal Bub1 1º 1:50 Meraldi et al. (2004) 
Anti-mouse Alexa Fluor 488® 2º  1:200 Stratech 
Anti-mouse Alexa Fluor 594® 2º 1:200 Stratech 
Anti-mouse Alexa Fluor 647® 2º 1:200 Stratech 
Anti-human Alexa Fluor 488® 2º 1:200 Stratech 
Anti-human Alexa Fluor 594® 2º 1:200 Stratech 
Anti-human Alexa Fluor 647® 2º 1:200 Stratech 
Anti-rabbit Alexa Fluor 488® 2º 1:200 Stratech 
Anti-rabbit Alexa Fluor 594® 2º 1:200 Stratech 
Anti-rabbit Alexa Fluor 647® 2º 1:200 Stratech 
 
Table 2.2. Primary and secondary antibodies used in MI and MII oocytes. 
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Figure 2.2. Examples of oocytes excluded from final analysis. (a) GV stage oocyte. 
Circular GV structure containing oocyte chromosomes can be visualised within oocyte. (b) 
Oocyte with multiple spindles. (c) Oocyte of unclear stage; there is neither GV nor polar body, 
indicating it is in metaphase I, but the chromosomes are clumped closely together with no 
obvious bivalent structures. (d) Telophase stage oocyte: CENP-E (green) can be seen 
localising to the midbody (marked with arrow) of the spindle. DAPI staining forms two patches 
on either side of the midbody, one of which is destined for the polar body, the other to remain 
in the oocyte. (e) MI oocyte with abnormalities. Although there are 23 bivalents present in this 
oocyte, each associated with four kinetochores, there are two additional DNA structures 
present towards the upper left region of the image, each of which contain 22 kinetochores. (f) 
Oocyte of unclear stage; there is no polar body indicating this is in MI, supported by the fact 
that there are approximately 92 kinetochores, however chromosomes do not appear to be in 
bivalent structures and instead the oocyte appears to contain mostly univalents associated 
with two kinetochores each.
Figure 2.2
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oocytes were fixed and stained. These were used for testing alternative 
antibodies and for analysis of intra-kinetochore distances. 
 
2.1.6. Antibody testing 
 
Because CREST stains multiple inner kinetochore and centromere proteins, I 
wanted to use an inner-kinetochore specific antibody to mark the inner 
kinetochore. Multiple anti-CENP-A antibodies, as well as antibodies against 
CENP-H and CENP-C, all of which are markers specific to the inner 
kinetochore, were tested (details of antibodies are given in Table 2.3). These 
antibodies were tested on MII oocytes, which were more readily available (as 
unfertilised oocytes), than oocytes in MI, and were fixed and stained in the same 
way as MI, as described above. Three different concentrations were tested for 
each antibody: 1:10, 1:20 and 1:50. None of these antibodies were successful 
in staining the inner kinetochore in oocytes, with most demonstrating no 
specificity for the kinetochore (for examples, see Figure 2.3). 
 
2.2. Imaging and image analysis 
 
2.2.1. Imaging 
 
All imaging was performed on an UltraView spinning-disk confocal microscope 
controlled by Volocity software (Perkin Elmer). Oocytes were imaged under the 
488, 561, 640 and 405 wavelengths. Laser power was set to 5% for the 405, 
488 and 640 wavelengths, and an image exposure time of 50 ms was used. For 
the 561 wavelength, laser power was set to 2% and an exposure time of 30 ms 
was used. Image stacks were collected using a 100x NA1.4 oil objective. 
Approximately 250 z-slices were taken over the spindle region of each oocyte 
separated by 50 nm (covering a total z-distance of 12.5 µm). To obtain images 
of the entire oocyte, a 60x NA1.4 oil objective was used, with around 100 z-
slices taken, covering a z-distance of 100 µm. MII oocyte images were acquired 
using the same settings, but with z-spacing of 100 nm. 
 
48
Table 2.3. 
 
Antibody Source 
Anti-CENP-A (mouse monoclonal) Abcam (ab13939) 
Anti-CENP-A (mouse monoclonal) Enzo Life Sciences (ADI-KAM-CC006-E) 
Anti-CENP-A (mouse monoclonal) Thermo Pierce (PIEAMA120832) 
Anti-CENP-A (rabbit polyclonal) Cell Signaling Technology (2186) 
Anti-CENP-C (rabbit polyclonal) Abcam (ab33034) 
Anti-CENP-H (mouse monoclonal) Abcam (ab77207) 
Anti-Rec8 (mouse polyclonal) Garcia-Cruz et al. (2010) 
 
Table 2.3. List of all primary antibodies tested in MI/MII oocytes. These antibodies were 
tested at concentrations of 1:10 to 1:20 and 1:50, but none were successful when used in 
oocytes. 
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Figure 2.3
Figure 2.3. Antibody testing in metaphase II oocytes. (a–e) MII stage oocytes immunos-
tained with CREST antisera, DAPI and an antibody against either CENP-A, CENP-C or 
CENP-H (all in a 1:50 dilution). Antibody details are given in Table 2.3. In (a), CENP-A stains 
the general spindle area, but does not show any specificity for kinetochores. The other 
antibodies did not show any specificity. Scale bars = 2 µm.
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2.2.2. Image deconvolution 
 
To improve the quality of the images and reduce the effects of out-of-focus 
blurring introduced by the limited aperture of the objective, images were 
deconvolved prior to analysis. Image stacks were deconvolved in Huygens X11 
software (Scientific Volume Imaging B.V.) which generates a theoretical point-
spread function (PSF) from the imaging parameters for each channel. 
Parameters input into the software for each channel included: excitation and 
emission wavelengths, numerical aperture (NA) of lens, sampling intervals, 
mounting medium and thickness of coverslip. The software generates a PSF 
from this data, which it uses to deconvolve the images.  
 
2.2.3. Classification of kinetochores pairs in meiosis I 
 
All image analysis was performed on image stacks acquired using the 100x 
objective and deconvolved as described above. Kinetochores were classified in 
Fiji software and in Imaris (Bitplane). To begin with, all kinetochores or 
kinetochore pairs were manually marked in Fiji and each point saved as a 
‘region of interest’ (ROI). Image stacks centred about each ROI were then 
produced. These were 2 x 2 µm and incorporated 20 z-sections (10 sections 
above and 10 below each point). Using the stacks, it was possible to identify 
distinct sister kinetochore pairs (a pair made up of two distinct CREST foci) and 
single CREST foci that could represent a single kinetochore or a pair of 
overlapping kinetochores. Some of these single spots had an elongated 
appearance (see Figure 3.5a for representative images), indicating that they 
represented more than one kinetochore pair. A decision tree for kinetochore 
classification is shown in Figure 2.4. 
 
To be able to determine whether single spots represented overlapping sister 
kinetochore pairs or single kinetochores, image stacks of oocyte kinetochores 
(CREST) and chromosomes (DAPI) were reconstructed in 3D in Imaris 
(Bitplane) to identify bivalents and thus deduce whether CREST foci associated 
with that bivalent corresponded to a single kinetochore or a pair of kinetochores.  
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Bivalents could be identified by counting the total number of discrete 
chromosomal structures within a cell and then assessing their relative sizes. For 
instance, if an oocyte contained 23 discrete structures, it was likely that each 
structure represented a bivalent (as there are 23 bivalents in a normal MI 
oocyte). In some cases, more than 23 structures were identified within a cell: 
usually 24, with 22 larger structures and 2 smaller ones. In these cases, the 
larger ones were deemed to represent bivalents and the smaller ones univalents 
(see Figure 3.15c). Bivalents could also be identified by assessing the CREST 
signal associated with each; in many cases, the larger structures were 
associated with at least one distinct kinetochore pair, providing reassurance that 
they were indeed bivalents. 
 
If foci could not be reliably classified, for instance due to overlapping 
chromosomes or kinetochore signal, they were classified as unclear. This gave 
rise to the following final four categories: 
 
• Distinct pair: A pair of sister kinetochores that appear as two separate 
spots. 
• Overlapping pair: A pair of sister kinetochores comprising a single spot. 
• Unpaired: A single kinetochore with no clearly identifiable partner, or far 
away enough from its partner to no longer be considered as part of a 
side-by-side sister kinetochore pair (>1.2 µm). 
• Unclear: Cannot be reliably classified as a pair or single kinetochore, 
usually due to unclear or overlapping DAPI or CREST signals. 
 
2.2.4. Measurement of inter-kinetochore distances 
 
Inter-kinetochore distances were measured using both CREST and CENP-E to 
mark individual kinetochores. Inter-kinetochore distance was measured using 
the FindFoci plugin in ImageJ, which identifies regions of peak intensity in 3D 
image stacks (Herbert, Carr, & Hoffmann, 2014). Peaks were identified in 2 x 2 
µm image stacks incorporating 40 z-sections that were centred about manually 
marked kinetochore pairs. The Pythagorean formula was used to calculate inter-
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Figure 2.4
Figure 2.4. Decision tree for classification of kinetochores in metaphase I stage human 
oocytes. Kinetochore classification was initially performed using high-resolution 2 x 2 µm 
image stacks (incorporating 20 z-sections) centred about marked CREST foci. Using the 
stacks, it was possible to identifiy and categorise distinct sister kinetochore pairs which 
consist of a pair of sister kinetochores represented by two distinct CREST foci. To determine 
whether single spots (one CREST focus) represented overlapping kinetochore pairs or single 
kinetochores, image stacks of oocyte kinetochores (CREST) and chromosomes (DAPI) were 
reconstructed in 3D in Imaris. This enabled identification of bivalents and univalents, and 
hence enabled the CREST foci associated with each to be classified. Foci  associated with 
regions of chromatin that could not be reliably identified as a bivalent or univalent were 
classified as unclear. In total, there were four classes of kinetochore: Distinct pairs, 
Overlapping pairs, Unpaired and Unclear.
Kinetochore classification using 2x2 µm 
image stacks incorporating 20 z-sections. 
How many CREST foci constitute the 
kinetochore / kinetochore pair?
Distinct 
kinetochore pair
Overlapping 
kinetochore pair
Unpaired 
kinetochore Unclear
Reconstruction of single foci in 3D in 
Imaris with DAPI signal. Identification of 
bivalents, univalents, single chromatids. Is 
the single focus on a bivalent?
Is it on a univalent?
Yes
Yes No
No
Two
One
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kinetochore distance in 3D, using the x, y and z coordinates of each peak. 
Statistical analysis of inter-kinetochore measurements was performed in 
Microsoft Excel and R. 
 
2.2.5. Measurement of intra-kinetochore distances 
 
Measurement of intra-kinetochore distances was performed by Christopher 
Smith. For accurate measurement of intra-kinetochore distance it was first 
necessary to calculate the chromatic shift between different wavelengths. 
Chromatic shift corrections were calculated in MII oocytes stained with CREST 
antisera or anti-CENP-E antibody. Primary antibodies were detected using two 
secondary antibodies to enable calculation of chromatic shift for each 
fluorescent marker. Alexa Fluor 488® and Alexa 647® were localised to 
CREST, while Alexa 561® and Alexa 647® were localised to CENP-E. 
Distances between the two wavelengths of markers were calculated in 3D in 
MATLAB using Gaussian mixture-model fitting to identify the sub-pixel location 
of the centre of each spot (Armond et al., 2016). The median distance between 
the two wavelengths of the markers was used as the chromatic shift correction 
value for those wavelengths. In order to measure intra-kinetochore distances, 
Gaussian mixture-model fitting was used to locate the centre of 3D fluorescent 
spots stained with different kinetochore markers, including CREST, Bub1 and 
CENP-E. Intra-kinetochore distances above 300 nm were excluded because 
these were likely to represent distances between two neighbouring spots rather 
than the same spot. Intra-kinetochore distances were calculated in 2D, given 
the high degree of variability in the z-axis. Median values (± standard deviation) 
of distance distributions were given (rather than mean values) to minimise the 
effect of any extreme values at the upper ends of the distribution, which in this 
case were more likely to represent signal from neighbouring spots rather than 
the same spot. 
 
2.2.6. Statistical analysis 
 
Statistical analysis was performed in R or Microsoft Excel 2016. Pearson’s R 
correlation coefficient was calculated to measure correlation. A student’s t-test 
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was used to compare means for small sample sizes. A single-factor analysis of 
variance (ANOVA) was used to test whether the variations in the mean between 
the different age groups of women were significant (see Table 3.1). Following 
the ANOVA test, a post-hoc Tukey honest significant difference (HSD) test was 
used for pairwise comparison of age groups. Where box-and-whisker plots were 
used to represent data, the boxes represent the interquartile range, with the 
lower whiskers extending to the farthest point within 1.5 times the lower quartile, 
and the upper whiskers to the farthest point within 1.5 times the upper quartile. 
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Chapter 3: Results 
 
3.1. Introduction 
 
The first meiotic division in human females is highly error-prone, for reasons that 
have not been fully elucidated. During metaphase I (MI), sister kinetochores 
need to attach to microtubule fibres emanating from the same spindle pole, as 
opposed to mitosis and meiosis II in which sisters attach to opposite spindle 
poles. In yeast and mouse, this is achieved through close physical association 
of sister kinetochores, mediated by the monopolin complex and Meikin 
respectively. In humans, however, the mechanism for sister kinetochore co-
orientation is not known. Because human oocytes undergo a protracted spindle 
assembly period in which a high proportion of erroneous attachments form 
(Holubcova et al., 2015), it has been suggested that altered meiotic kinetochore 
geometry may be a factor that contributes towards this. Characterisation of 
human meiotic kinetochore organisation has not yet been achieved. In this 
chapter, I present the results of my investigations into kinetochore organisation 
in MI-stage human oocytes. 
 
3.2. Kinetochore geometry & architecture in meiosis I 
 
3.2.1. Sister kinetochores are not fused during meiosis I 
 
To investigate the organisation of meiotic kinetochores in females, I examined 
sister kinetochore pairs in MI-stage oocytes obtained from women undergoing 
assisted reproduction (IVF or ICSI) following hormonal ovarian stimulation. 
Patient details, including indications for undergoing assisted reproduction, are 
given in Table 2.1. Common reasons for undergoing treatment included 
polycystic ovarian syndrome (n = 4) and endometriosis (n = 3), however 
unexplained infertility (n = 6) was the most common reason. Oocytes presented 
in this chapter are those that had assembled the first meiotic spindle, but had 
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not yet undergone the first meiotic division; this was confirmed by the absence 
of a polar body (Figure 3.1). To avoid any changes to kinetochore geometry 
and to be able to examine meiotic chromosomes and kinetochores in situ, 
oocytes were fixed intact in 3.7% paraformaldehyde (PFA). In total, 27 MI stage 
oocytes were included in the final analysis (Figure 3.2). These 27 oocytes came 
from 20 patients (details in Table 2.1). 
 
To image kinetochores in human oocytes we fixed the cells and stained them 
with CREST antisera (to mark the centromere and inner kinetochore) and DAPI 
(to mark chromosomes). CREST is derived from the serum of CREST 
(calcinosis, Raynaud's phenomenon, esophageal motility abnormalities, 
sclerodactyly and telangiectasia) patients and contains anticentromeric 
antibodies (Fritzler & Kinsella, 1980). 3D image stacks (250 sections, spaced 
50 nm apart) were captured using an Ultraview spinning disk confocal 
microscope (see Methods for details) and images were deconvolved using 
Huygens software. Kinetochores, marked with CREST antisera, were analysed 
in these image stacks using Fiji software. The use of closely-spaced z-sections 
(taken every 50 nm) enabled acquisition of detailed information on oocyte 
chromosomes and kinetochores and their 3D arrangement (Figure 3.3a). In MI 
oocytes, the majority of kinetochores appeared to be in pairs made up of two 
distinct CREST foci (Figure 3.3b). In an MI oocyte in which all kinetochores 
were fused, I would have expected to see 46 CREST foci per oocyte (two foci 
per bivalent). However, the number of CREST foci within these oocytes was 
considerably higher than 46, and it was often possible to identify individual 
bivalents associated with four CREST foci, which indicated that sister 
kinetochores were not fused in MI (Figure 3.3c-d). However, in addition to these 
paired structures composed of two foci, there were also many structures 
consisting of a single CREST focus which may have represented a fused pair 
of sister kinetochores. To be able to determine whether these single foci 
represented a single kinetochore or a pair of kinetochores I used surface 
rendering in Imaris software to reconstruct the oocyte chromosomes and 
kinetochores in 3D. This enabled clear visualisation of individual bivalents and 
the kinetochores associated with each (Figure 3.4), enabling me to determine 
whether a single spot corresponded to a kinetochore pair. 
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maximum intensity projection
MI stage human oocyte, 60x (z-projection)
CREST
DAPI
ooplasm
oocyte chromosomes
sperm head
Figure 3.1. 60x maximum intensity projection of an metaphase I stage human oocyte. 
Chromosomes are stained with DAPI (blue) and kinetochores with CREST antisera (red). 
Image was formed from 80 z-slices, taken every 1 µm, and acquired on a spinning-disk 
confocal microscope. The absence of a polar body indicates that this oocyte has not yet 
undergone the first meiotic division. As this oocyte was acquired from an IVF cycle, it has 
been incubated overnight with a sperm preparation, hence the chromosomes from a 
spermatozoon can be seen towards the top right edge of the oocyte. Scale bar = 10 µm.
Figure 3.1
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Figure 3.2a
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Figure 3.2b
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vi. 1285a6
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Figure 3.2c
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i. 1280a1
34.9 years
ii. 1282a2
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iii. 1317a1
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v. 1331a1
33.8 years
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Figure 3.2d
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CREST
DAPI
i. 1333a1
32.1 years
ii. 1237b1
27.7 years
CREST
α-tubulin
oocytes without DAPI staining
iii. 1245a2
28.6 years
CREST
Figure 3.2e
Figure 3.2. (a–e) Maximal projection images of all metaphase I oocytes for which 
kinetochore pairs were analysed (n = 27 in total). For each oocyte, its unique oocyte 
identification code and the age of the donating patient are given. For the final two oocytes 
shown, I was unable to acquire clear DAPI channel images, therefore these are shown 
without. Note that for some oocytes (1331a1, 1332a1, 1285a4, 1285a1, 1285a3) there is 
‘granular’ CREST staining which is present throughout the entire oocyte cytoplasm. Despite 
this staining pattern, CREST is still highly specific to the kinetochores, as can be seen in the 
images, therefore these oocytes have been included in the final analysis.
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d
Figure 3.3. Kinetochores in image stacks of metaphase I stage human oocytes. (a) A 
montage of z-projections of the chromosomes from a metaphase I oocyte, with each image 
incorporating information from 10 z-slices. Each z-section is spaced 50 nm apart, therefore 
each image covers a z-distance of approximately 500 nm. (b) Left panel shows a 100x 
close-up of the chromosomes and kinetochores in this oocyte. (c) Z-projection images 
incorporating 20 x 50 nm z-slices centred about a manually marked kinetochore pair (centre 
of panel). Sister kinetochore pairs on homologous chromosomes are shown alongside each 
other. Panels are 4 x 4 μm. (d) Individual bivalents from this oocyte, each associated with 4 
kinetochores. Panels are 4 x 4 μm.
z: 1-10 z: 11-20 z: 21-30 z: 31-40 z: 41-50 z: 51-60
a
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Figure 3.4. 3D reconstruction of oocyte chromosomes. Reconstruction of chromosomes 
and (blue) and kinetochores (red) in Imaris (Bitplane) from a high-resolution stack acquired 
using spinning-disk confocal microscopy. The maximal projection image of this oocyte is 
shown in Figure 3.2c(iv). Upper panel shows the entire set of chromosomes from this oocyte 
and lower panels show individual bivalents and the kinetochore pairs associated with each.
Figure 3.4
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 Using a combination of 3D image stacks centred about kinetochore pairs and 
3D reconstruction in Imaris, kinetochores in the 3D image stacks were classified 
on the basis of whether they appeared as part of a ‘distinct’ pair (made up of 
two distinct CREST spots) or ‘overlapping’ pairs (appearing as a single spot). 
For examples, see Figure 3.5a. In total, it was possible to classify the majority 
of kinetochores in all 27 oocytes, however a small proportion (1.1%) could not 
be reliably classified due to overlapping DAPI and/or CREST staining. The 
majority (72.1%) of kinetochores were identified as being within a distinct pair, 
with an average of 33 (range: 19–44) distinct pairs per oocyte (Figure 3.5b). 
The remaining 22.9% of sister kinetochore pairs were classified as 
‘overlapping’, with an average of 10 (range: 0–22) overlapping pairs per oocyte. 
A small proportion (3.8%) of foci were classified as ‘single’ kinetochores if they 
had no clearly identifiable partner or if they had come far apart enough from 
their partner (>1.2 µm) to be considered as a single kinetochore. The ‘single’ 
kinetochores were often found on univalents (bivalents that have come apart), 
and are examined in greater detail in section 3.3.3. There were no differences 
in oocytes from women with no known fertility issues, i.e. couples with male 
factor infertility (marked with asterisks in Figure 3.5c; see also Table 2.1), 
indicating that these observations are unlikely to result from infertility factors. In 
addition, there was no correlation between the total dose of FSH received by 
patients and the proportion of separated sister kinetochores (Pearson’s R = 
0.111; Methods Figure 2.1). Together, these results indicated that sister 
kinetochores in MI were routinely separated in human MI oocytes. 
 
To quantify the degree of separation, I measured the inter-kinetochore distance 
between distinct sister pairs. Distances were measured in 3D using the peak 
intensity of the CREST signal, detected in Fiji using the FindFoci plugin (Herbert 
et al., 2014), to mark individual kinetochores. The average degree of separation 
between sister kinetochores in MI was 0.69 ± 0.20 µm (mean ± SD; n = 818 
pairs from 27 oocytes). Based on this information, I concluded that the inner 
plates of sister kinetochore pairs in MI human oocytes can be separated. This 
is in stark contrast to what is known about mouse MI oocytes in which sister 
kinetochores are fused together by Meikin (Kim et al., 2015), suggesting that in 
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Figure 3.5. Kinetochore classification in metaphase I oocytes. (a) Examples of 
kinetochore classification images taken from 3 different oocytes. Images are 4 x 4 µm 
maximal projections incorporating 10 z-sections taken above and below a manually-marked 
kinetochore/kinetochore pair (20 z-sections total). To verify that ‘single’ kinetochores were 
true singles and not overlapping pairs, they were examined in Imaris. (b) Box-and-whisker 
plot showing mean percentage of each class of kinetochore/kinetochore pair for each oocyte, 
classified according to whether kinetochores were within distinct or overlapping pairs (n = 
2456 kinetochores from 27 oocytes). For a small number of kinetochores, sister kinetochores 
were so far apart (>1.2 μm) that they were classified as ‘unpaired’. A small number of foci 
could not be reliably identified as being either single kinetochores or overlapping pairs, 
usually due to overlapping CREST or DAPI fluorescence from neighbouring bivalents, and 
these were classified as ‘unclear’. (c) Proportion of distinct and overlapping pairs for each 
individual oocyte. Asterisks indicate oocytes from women with no known fertility issues.
Figure 3.5
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human MI oocytes there may be a different method of establishing sister 
kinetochore association. 
 
3.2.2. The inner, outer and corona regions of each kinetochore are distinct 
 
Having established that the inner plates of the kinetochore were separated in 
human MI, I next sought to determine whether the entire kinetochore structure 
(from the inner to outer regions) was separated. As CREST antisera stains only 
the inner kinetochore and centromere, it does not provide information on 
whether the outer regions of the kinetochore (the outer plate and fibrous corona) 
are separated. In maize, for instance, the inner plate of the kinetochore is 
separated in MI but the outer plate, the region responsible for attachment to 
microtubules, forms a ‘bridge’ structure that can be visualised under 
immunofluorescence microscopy (Li & Dawe, 2009). It was therefore a 
possibility that this arrangement also applied in human oocytes. To test this, the 
outer regions of the kinetochores of human MI oocytes were labelled using 
antibodies against Hec1 (to mark the outer plate) and CENP-E (fibrous corona) 
(Wan et al., 2009, Earnshaw, 2015); see Figure 3.6a. Because the Hec1-9G3 
antibody showed high levels of background staining and only weakly stained 
kinetochores in a few oocytes, an additional outer plate marker, Bub1, which is 
located in a similar position within the kinetochore to Hec1, was tested (Wan et 
al., 2009). This antibody demonstrated a more consistent staining pattern 
(Figure 3.6b). Comparing these outer kinetochore markers with that of the inner 
kinetochore (marked by CREST) showed that the staining patterns of outer plate 
and fibrous corona kinetochore markers resembled those of the inner 
kinetochore, indicating that the entire kinetochore structure is separated in MI. 
 
The degree of separation was compared in oocytes that had both CENP-E and 
CREST staining (n = 24 oocytes) to test whether the outer kinetochore was 
separated to a similar degree as the inner kinetochore. There was a strong 
correlation between CREST and CENP-E measurements that had been made 
for the same kinetochore pairs (R = 0.80; Figure 3.7a), indicating that the entire 
inner and outer plate are separated to a similar degree. However, using CREST 
as a marker, the overall mean (± SD) inter-kinetochore distance was 0.69 ± 0.21 
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CREST CENP-E Bub1
CREST CENP-E Hec1 (9G3)
Oocyte stained with CREST, CENP-E and Hec1
Figure 3.6. The entire kinetochore is separated in the majority of metaphase I oocytes. 
(a-b) Oocytes stained with markers for the kinetochore inner plate (CREST), outer plate 
(Hec1 or Bub1) and fibrous corona (CENP-E). The pattern of staining for individual 
kinetochore pairs does not differ between markers, which shows that, in distinct kinetochore 
pairs, the entire kinetochore is separated.
Figure 3.6
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µm for all pairs (similar to the average across all 27 oocytes) and for CENP-E it 
was slightly increased to 0.75 ± 0.23 µm. Figure 3.7b), which may indicate that 
the outer region of the kinetochore is separated to a greater degree than the 
inner plate. However, using a t-test to compare the two means, the difference 
between the groups was not significant (p = 0.2969), indicating that this is a 
minimal effect. Together, these data show that the entire kinetochore structure 
is separated in MI. 
 
3.2.3. Kinetochore architecture in metaphase of meiosis I 
 
In mitosis, the inner architecture of the kinetochore changes depending on 
kinetochore attachment status. Stretching of centromeric chromatin between 
mitotic sister kinetochores is needed to stabilise bipolar attachment (Lampson 
& Cheeseman, 2011) and can impose conformational changes within the 
kinetochore (Wan et al., 2009). In meiosis, however, because sister chromatids 
segregate together, a ‘side-by-side’ arrangement of sister kinetochores is 
adopted, with the outer plates of both sisters oriented towards the same spindle 
pole and inner plates facing the centromeres. By fixing whole intact oocytes, it 
was also possible to visualise the side-by-side arrangement of sister 
kinetochores, and show that the inner kinetochore (CREST) is located towards 
the centromeric chromatin, with the outermost region of the kinetochore (CENP-
E) facing outwards towards the spindle (Figure 3.8). 
 
To test whether this side-by-side arrangement of sisters alters the internal 
architecture of the kinetochore, the intra-kinetochore distance between markers 
of the kinetochore inner plate/centromere (CREST), outer plate (Bub1) and 
fibrous corona (CENP-E) was measured in both MI and MII oocytes. To do this, 
a modified version of kinetochore-tracking software developed in MATLAB 
(Armond et al., 2016) was used to identify individual kinetochores in different 
channels, with each channel corresponding to a different marker. The software 
fits a 3D Gaussian to the fluorescent spots in different channels to find the sub-
pixel spot centre coordinates, which are then manually filtered for quality. The 
distance between the spot centres in different channels gives the intra-
kinetochore distance in 3D. The distances were chromatic shift-corrected using 
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Figure 3.7. Comparison of inter-kinetochore distance as measured using CREST and 
CENP-E. (a) Strong correlation between measurements for kinetochore pairs for which 
distance was measured using both CREST and CENP-E as markers showing that the outer 
kinetochore separates to the same degree as the inner kinetochore. (b) Frequency density 
chart comparing CREST and CENP-E inter-kinetochore distances. CENP-E gives a slightly 
higher mean inter-kinetochore distance than CREST, however using a comparison of two 
means t-test, the difference between the two groups is not significant (p = 0.2969).
Figure 3.7
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a
Metaphase I bivalent
side-by-side arrangement of 
sister kinetochores
b
DAPI
CREST
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fibrous 
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sister kinetochores
Figure 3.8. Relative arrangement of inner and outer kinetochore components in 
metaphase I oocytes. (a) 3D reconstruction of MI oocyte chromosomes in Imaris (Bitplane) 
from an oocyte stained with CREST antisera (red), anti-CENP-E antibody (green) and DAPI 
(blue). Right panel: individual bivalents shown in closer detail, in which the relative positions 
of CREST and CENP-E staining can be clearly visualised. (b) Schematic of a bivalent in MI, 
showing side-by-side arrangement of sister kinetochores. The inner plate of the kinetochore 
(here shown in red) is oriented towards the centromeric chromatin.
Figure 3.8
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chromatic shift values calculated from MII oocytes stained with a single primary 
antibody (CREST or anti-CENP-E) detected by two secondary antibodies with 
different fluorescent tags. 
 
In MI, the distance between CREST and CENP-E was measured as 151 ± 60 
nm (median ± SD; n = 162 kinetochores), with a smaller distance of 129 ± 36 
nm (n = 32) measured between CREST and Bub1 (Figure 3.9). Thus, CENP-E 
is located approximately 22 nm outside of Bub1, consistent with measurements 
of the same proteins on human mitotic kinetochores (Wan et al., 2009). In MII, 
the distance between CREST and CENP-E was measured as 156 ± 54 nm 
(median ± SD; n = 176 kinetochores). The software was not able to detect 
enough spots for the CREST to Bub1 distance to be measured, but CENP-E to 
Bub1 was measured as 36 ± 27 nm (median ± SD; n = 17 kinetochores). 
Common to both MI and MII measurements was a longer distance between the 
kinetochore inner plate (represented by CREST) and outer plate / fibrous corona 
(represented by Bub1 and CENP-E respectively) than in mitosis, suggesting 
that the kinetochore is further stretched in meiosis. 
 
One limitation of this experiment is that my marker for the inner plate, CREST, 
stains the centromere and multiple inner kinetochore markers (including CENPs 
A, B and C) (Earnshaw, 2015). Moreover, we cannot use CREST in mitotic cells 
as it locates throughout the centromere making tracking spots impossible. As a 
result, it is difficult to make comparisons between meiosis and mitosis. To solve 
this, I attempted to stain kinetochores in oocytes with a different marker that was 
specific to the inner plate, such as CENP-A, CENP-C or CENP-H. However, 
none of the inner plate antibodies tested demonstrated any specificity for the 
inner kinetochore when used in MII oocytes (see Figure 2.1). 
 
3.2.4. Sister kinetochores in meiosis I form dual k-fibre attachments 
 
Because the outer plates of sister kinetochores were separated in MI, I next 
studied how they form attachments to spindle microtubules. Understanding this 
is important, because in MI sisters need to attach to the same, rather than 
opposing, spindle poles. If sisters are separated, this raises questions about 
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Figure 3.9. Map of kinetochore architecture in meiosis I and II stage oocytes, with 
mitotic kinetochore architecture shown for comparison. As Bub1 staining was common 
to all, measurements are given relative to Bub1. For meiosis, CREST and CENP-E are 
shown as box-and-whisker plots to show the spead of data. The positioning of the medians 
of the plots are given relative to Bub1 (designated as 0). In meiosis I, the red box-and-whisker 
plot represents the CREST-Bub1 distance, and the green represents the CREST-CENP-E 
distance. In meiosis II, the red represents the CREST-CENP-E distance and the green the 
CENP-E-Bub1 distance. Grey solid lines represent measured distances, with n representing 
the number of kinetochores. Dotted lines represent inferred distances. A caveat of these 
measurements is that we were unable to stain CENP-A (or another inner kinetochore-specific 
marker) in oocytes, which makes it difficult to assess whether the extended length of the 
kinetochore inner plate in meiosis is of significance. 
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how they form attachments to the same spindle pole. A possible model for 
meiotic sister kinetochore attachment is one in which only one ‘active’ sister 
forms attachments to microtubules, and the other sister is inactivated. 
Alternatively, both sisters may remain ‘active’ and capable of binding to spindle 
microtubules. To test this, I examined kinetochore-microtubule attachments in 
oocytes subjected to cold-shock treatment and then stained with antibodies 
against α-tubulin and kinetochores. Cold treatment causes most microtubules 
to depolymerize, however microtubules attached to the outer kinetochore plate, 
specifically to Hec1/Ndc80, are resistant to this effect (Miller et al., 2008). This 
makes it easier to visualise end-on attachments within the meiotic spindle. In a 
small number of cases (n = 5 sister kinetochore pairs from three oocytes), I 
observed pairs in which one kinetochore was attached to a k-fibre but its sister 
was not. However, more frequently, I noted the presence of kinetochore pairs 
with dual k-fibre attachments (n = 20), in which each sister within the pair was 
attached to a distinct k-fibre (Figure 3.10). These attachments were observed 
in both distinct (18/20) and overlapping (2/20) kinetochore pairs, thereby 
showing that homologous chromosomes can connect to the meiotic spindle via 
two independent attachment sites. This surprising result may make the process 
of bi-orientation challenging in MI compared to MII (or mitosis). 
 
3.3. The effect of maternal age 
 
3.3.1. Introduction 
 
The relationship between maternal age and aneuploidy in oocytes is well 
established (Hunt & Hassold, 2008). Many studies investigating maternal age-
related aneuploidy have focused on cohesin (Jessberger, 2012), because of the 
role that it plays in keeping sister chromatids together during the long arrest 
period of the oocyte. Loss of cohesin, particularly at the centromeres, could 
impact on sister kinetochore organisation and architecture in MI. Given that the 
oocytes I studied had originated from women of various ages, I sought to identify 
whether there were any changes in MI sister kinetochore geometry with age that 
could reflect a decline in cohesin. 
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Figure 3.10. Sister kinetochore pairs in metaphase I engage with independent 
kinetochore-fibres. (a) Maximal projections of two MI human oocyte spindles stained for 
microtubules (green, alpha-tubulin) and kinetochores (red, CREST) after cold-shock 
treatment. (b) Enlarged z-sections of kinetochore pairs from 3.10a with dual and monotelic 
attachments as indicated. Scale bar = 2 µm.
Figure 3.10
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 3.3.2. Sister kinetochores are further apart with increasing maternal age 
 
As kinetochores are connected by centromeric chromatin, the distance between 
them can act as a proxy for the status of cohesin.  To investigate whether there 
were signs of cohesin decline in older oocytes, I first analysed whether the 
proportion of distinct kinetochore pairs within each oocyte increased with age, 
which would reflect the coming apart of sister kinetochores. I found that there 
was not a significant relationship (Pearson’s correlation coefficient, R = 0.283) 
between age and proportion of distinct pairs in this sample (Figure 3.11a), 
although in the two youngest patients (ages 26.2 and 27.7) a smaller proportion 
of kinetochore pairs were classified as ‘distinct’ (52.2% and 42.2% respectively, 
compared to 72.6% for all oocytes). When comparing kinetochore 
classifications by age group, the differences remained negligible between the 
‘under 33’ and ‘mid-30s’ age groups (69.8% and 70.4% respectively), with a 
slight increase to 77.0% for the ‘over 38’ age group (Figure 3.11b). Together, 
this data does not indicate that there is a relationship between female age and 
separated sister kinetochores. 
 
Although the proportions of separated sister kinetochores did not increase with 
age, I noticed that in oocytes from older women, sister kinetochore pairs 
appeared to be further apart than in oocytes from younger patients (Figure 
3.12). I therefore examined inter-kinetochore distance measurements in the 
context of age. Using CREST as a kinetochore marker, I found that there was a 
gradual increase in inter-kinetochore distance with age (n = 27 oocytes; 
Pearson’s correlation coefficient, R = 0.645; Figure 3.13a). As the majority of 
aneuploidies in human embryos arise when a woman is in her mid to late thirties 
(Hassold & Hunt, 2001), I compared oocytes from women under 33 years of 
age (age range: 26.2–32.4 years) with oocytes from women in their mid-30s 
(age range: 33.8–35.5 years) and those over 38 years of age (age range: 38.4–
40.7 years). These specific ages were selected because they ensured a clear 
distinction in age between each of the groups. Using a single-factor ANOVA, 
there was a significant difference in inter-kinetochore distance between age 
groups for both CREST (p = 0.00265) and CENP-E (p = 0.00225). For CREST, 
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Figure 3.11. No relationship between the proportion of distinct pairs and patient age. 
(a) Percentage of distinct pairs within each oocyte. Each cross represents a single oocyte. 
Pearson’s correlation coefficient, R = 0.283. (b) A comparison of the average proportion of 
distinct kinetochore pairs by age group. All patients in the ‘mid-30s’ group were aged between 
33.8–35.5 years. The cut-offs for each age group were selected because they ensured a 
clear gap between the oldest members of the younger age groups and the youngest 
members of the next age group up.
Figure 3.11
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Figure 3.12. Sister kinetochores in older oocytes are further apart. Upper panels show 
maximal projection images of an oocyte from a 26-year-old woman compared with one in the 
lower panels from a 38-year-old woman. Scale bar = 2 μm.
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Figure 3.13. Inter-kinetochore distance between sister kinetochores in meiosis I 
increases with maternal age. (a) Increasing inter-kinetochore distance with female age 
using (a) CREST to mark the kinetochore. Patients with no known fertility problems (n = 5) are 
highlighted in yellow. Box plot shows comparison of inter-kinetochore distance between 
women under 33 years of age with women over 38 (p<0.0001, unpaired t-test). (b) The same 
measurements using CENP-E as a marker for the kinetochore. Patients numbers correspond 
to those shown in Table 2.1. R = linear correlation coefficient. Boxplots represent interquartile 
range (IQR); whiskers extend to most extreme value within 1.5*IQR.
Figure 3.13
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post-hoc comparisons using the Tukey HSD test with a 0.05 level of significance 
showed that the difference between the Under 33 and Mid-30s group was not 
significant. However, there were significant differences between the Under 33 
and Over 38 group (p<0.05), going from 0.63 ± 0.18 µm in the younger group to 
0.76 ± 0.22 µm in the older group. Post-hoc comparisons also showed a 
significant difference between the Mid-30s and Over 38 group (p<0.05), going 
from 0.66 ± 0.18 µm to 0.76 ± 0.22 µm (see Table 3.1). This is in keeping with 
the observed increase in MI-derived aneuploidy in oocytes from women in their 
mid to late thirties. 
 
To test whether the entire kinetochore structure comes apart with age, we also 
looked at the relationship between patient age and inter-kinetochore distances 
measured with CENP-E, an outer kinetochore marker. As with CREST, there is 
a gradual increase in inter-kinetochore distance (n = 24 oocytes; R = 0.645; 
Figure 3.13b). The difference in inter-kinetochore distance between the ‘under 
33’ and ‘over 38’ age groups is also significant (p<0.0001), rising from 0.69 ± 
0.23 µm in the under 33 group to 0.83 ± 0.22 µm in the over 38 group. The 
subset of oocytes from women with no known fertility issues (n = 5; marked in 
Figure 3.13 and see also Table 2.1) also fit this trend suggesting that this effect 
does not arise as a result of clinical factors. There was weak correlation between 
the total FSH dose received by each woman and inter-kinetochore distance (R 
= 0.415; Figure 2.1), which may indicate that exogenous gonadotrophin 
exposure has a small contribution towards this effect. In mouse, FSH exposure 
affects chromosome alignment, with chromosomes in oocytes exposed to high 
FSH more scattered about the spindle (Roberts et al., 2005). Because oocytes 
included in this study were fixed in varying stages of MI it was not possible to 
reliably ascertain the level of chromosomal scattering. Overall, this data shows 
that sister kinetochore separation increases with female age, which supports 
the idea that there is a decline in centromeric cohesin with age. 
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Table 3.1. 
a. Inter-kinetochore distance measurements 
 CREST CENP-E 
Age group Mean ± SD (µm) n Mean ± SD (µm) n 
Under 33 0.63 ± 0.18 267 0.69 ± 0.23 207 
Mid-30s 0.66 ± 0.19 237 0.72 ± 0.21 213 
Over 38 0.76 ± 0.22 314 0.83 ± 0.22 286 
All 0.69 ± 0.20 818 0.75 ± 0.23 706 
 
b. Tukey post-hoc HSD comparison 
 
CREST CENP-E 
Comparison Abs difference in mean (µm) 
>HSD Abs difference 
in mean (µm) 
>HSD 
Under 33 Mid-30s 0.038 
 
0.042 
 
Mid-30s Over 38 0.092 * 0.107 * 
Over 38 Under 33 0.130 * 0.149 * 
 
Table 3.1. Inter-kinetochore measurements using CREST and CENP-E to mark 
individual kinetochores. (a) Table shows mean ± SD inter-kinetochore distances for the two 
different kinetochore markers for each of the three age groups. A one-way analysis of variance 
(ANOVA) test yielded a significant difference between the age groups for both CREST (p = 
0.00265) and CENP-E (p = 0.00225). (b) The ANOVA was followed up with a Tukey post-hoc 
HSD test to conduct a pairwise comparison between the age groups. If the absolute difference 
in means between two groups is greater than the HSD value (calculated using a significance 
level of 0.05) then the difference is considered to be significant. For CREST, the HSD was 
calculated to be 0.0506, and for CENP-E it was 0.0551. For both CREST and CENP-E, 
comparing the two younger age groups did not yield a significant difference. However, 
comparing the Over 38 age group with the two younger groups did. Abs: absolute. HSD: 
honestly significant difference. n: number of sister kinetochore pairs. SD: standard deviation. 
*represents a significant difference. 
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3.3.3. Univalents are the most common abnormality in metaphase I 
oocytes 
 
Given that there was an apparent decline in cohesin with age, the next question 
I asked was whether there were any abnormalities in chromosome configuration 
(for instance, the presence of single chromatids or univalents) in the oocytes 
included in the analysis that could have arisen as a result of cohesin decline. As 
cohesin is involved in chiasmata maintenance, we would expect to see an 
increase in univalents (bivalents that have come apart) with cohesin loss. We 
would also expect to see single chromatids which can also arise as a result of 
cohesin loss. To identify whether the oocytes included in this research had any 
abnormalities in chromosome configuration that would make them prone to 
aneuploidy, I used Imaris and Fiji to identify individual bivalents within each 
oocyte and the kinetochores associated with each. In 17 oocytes, it was possible 
to account for the arrangement of all chromosomes. For the remaining oocytes 
in the population, the overlapping chromosomal staining made it impossible to 
identify all homologues definitively. Of the 17 oocytes, I identified 7/17 (41%) as 
having abnormal chromosome configurations (see Figure 3.14 for examples). 
Six of the seven contained univalents (bivalents that have come apart) and one 
oocyte contained two trivalents (see Table 3.2). The remaining 10 had the 
normal arrangement of chromosomes that we would expect in an MI-stage 
oocyte, i.e. 23 bivalents each associated with two pairs of sister kinetochores. 
There was a mild relationship with age, as the oocytes with normal 
chromosomal arrangements had an average age of 32.4 ± 2.9 years (mean ± 
SD), whilst those with abnormal arrangements had an average age of 35.6 ± 
3.6 years (p = 0.09, two-tailed t-test assuming unequal variance). 
 
Because cohesin is thought to play a role in maintenance of chiasmata, I 
hypothesised that oocytes with univalents (which can form as a result of 
chiasmata loss) would have overall reduced cohesin compared to oocytes with 
normal chromosomal architecture. To test this, I compared inter-kinetochore 
distances between normal oocytes (ones that contained 23 bivalents, each 
associated with two pairs of sister kinetochores) and those with some abnormal 
configurations of chromosomes (Figure 3.15a). Although the overall average 
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for the abnormal oocytes was slighter higher, only in 3/7 oocytes was the 
measurement higher than the average over all oocytes (Figure 3.15b). The 
remaining four did not have increased sister separation, and were in fact below 
the overall average for all oocytes. It may therefore be a possibility that cohesin 
loss occurs in a more localised manner, i.e. occurring on only a few 
chromosomes, rather than over all chromosomes of the oocyte. I therefore 
examined kinetochore pairs on individual univalents (Figure 3.15c). Of the 15 
univalents, 12 had kinetochore pairs that appeared to be bi-oriented. The inter-
kinetochore distances between these bi-oriented kinetochores was generally 
significantly larger than the inter-kinetochore distance between all kinetochores, 
with a mean separation distance of 1.70 µm (n = 12 pairs, range: 1.25–2.82 
µm), indicating that centromeric cohesin between these pairs had been 
depleted (Figure 3.15d). 
 
3.4. Conclusion 
 
Using high-resolution imaging in fixed intact human oocytes, I have 
demonstrated that the human meiotic kinetochore adopts a unique arrangement 
in which sister kinetochores in MI are routinely separated. We have shown that 
internal architecture of the kinetochore does not change from mitosis, and that 
each sister retains its ability to act as an independent attachment site. 
Importantly, we have shown that sister kinetochore separation increases with 
female age, which may reflect a decline in meiotic cohesin, and hence may 
contribute to the increased levels of aneuploidy we observe in oocytes from 
older women. 
  
84
Table 3.2. 
Oocyte 
code 
Age Mean inter-
kinetochore 
distance (µm) 
Abnormal chr 
config? 
(y/n) 
Details 
1291a1 26.2 0.441865095 n 23 bivalents 
1257b1 28.1 0.839032386 y 22 bivalents, 2 univalents 
1262a1 29.1 0.665095157 n 23 bivalents 
1282a2 30.2 0.604780421 n 23 bivalents 
1333a1 32.1 0.634653815 n 23 bivalents 
1274a2 32.4 0.660308085 n 23 bivalents 
1331a1 33.8 0.663418262 n 23 bivalents 
1325a2 34.7 0.634320797 y 22 bivalents, 2 univalents 
1280a1 34.9 0.763591841 n 23 bivalents 
1285a3 35.1 0.658027761 n 23 bivalents 
1285a4 35.1 0.687407925 n 23 bivalents 
1285a1 35.1 0.64807879 y 20 bivalents, 6 univalents 
1285a6 35.1 0.654302372 y 22 bivalents, 1 univalent 
1317a1 35.3 0.591870489 n 23 bivalents 
1277a1 38.3 0.961970221 y 20 bivalents, 2 trivalents 
1251a1 39.0 0.957105968 y 22 bivalents, 2 univalents 
1332a1 39.1 0.743011863 y 22 bivalents, 2 univalents 
Table 3.2. Details of chromosome configuration in oocytes for which all kinetochores 
could be accounted for. Oocytes are ordered by patient age at the time of egg collection. 
Oocytes with abnormal chromosome configuration, as designated in column 4, are highlighted. 
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Figure 3.14. 3D reconstruction of chromosomal arrangement in metaphase I oocytes. 
(a) Chromosomes from two normal oocytes, each with 23 bivalents. (b) Chromosomes in two 
abnormal oocytes, each with 22 bivalents (blue) and 2 univalents (yellow).
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Figure 3.15. Inter-kinetochore distances in oocytes in which chromosomal status 
could be assessed. (a) Mean inter-kinetochore distance in oocytes that had normal (n = 10) 
and abnormal (n = 7) chromosome arrangement. (b) Oocyte-wide inter-kinetochore distances 
in normal (green) and abnormal (red) oocytes, in comparison to the mean over all oocytes 
(dotted grey line). (c) Maximal projection images of univalents. (d) Chart showing 
inter-kinetochore distances for all univalents, which are higher than the overall average.
Figure 3.15
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Chapter 4: Discussion 
 
In this study, I aimed to characterise the organisation of the meiotic kinetochore 
in intact human MI oocytes. I found that, unlike in previous organisms studied, 
sister kinetochores are generally separated in MI, and that the distance of 
separation increases with increasing female age. 
 
4.1.  Use of human oocytes 
 
Study of human oocytes is challenging, given the invasive nature of oocyte 
collection, ethical considerations and scarcity of material. In addition to these 
impediments, the oocytes themselves are highly sensitive to variations in 
temperature and pH, requiring careful monitoring of external conditions 
(Pickering et al., 1990, Dale et al., 1998). The problem of access to material can 
be overcome to some extent by using oocytes from women undergoing fertility 
treatment. However, the oocytes available to research via this avenue are 
typically only those that are not suitable for use in the donating patient’s 
treatment. This raises potential concerns about the quality of the oocytes 
available because (a) they come from sub-fertile women and (b) they are 
oocytes that have failed to mature in vivo, despite exposure of the woman to 
hormonal stimulation aimed at producing mature (MII) oocytes. There are also 
concerns that the stimulation itself can be a contributor to aneuploidy. 
 
To provide some reassurance concerning these issues, I showed that women 
included in the study who have presumed normal fertility (i.e. they are 
undergoing IVF due to male-factor infertility or are in same-sex relationships) 
exhibit the same results as sub-fertile women. Furthermore, because the 
women in the study experience infertility for a range of different conditions, as 
presented in Table 2.1, it is highly unlikely that medical factors are responsible 
for the consistent results in kinetochore structure that were observed. To assess 
the effects of hormonal stimulation, I measured correlation between the total 
FSH dose received by patients and meiotic kinetochore features, and found that 
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it did not explain my observations (see Figure 2.1), although there was a mild 
correlation between total FSH dose and increased inter-kinetochore distance. 
Nonetheless, the results presented in this thesis are consistent with those of 
Zielinska et al., who studied human oocytes obtained from ICSI cycles, which 
would also have been exposed to a regimen of gonadotrophin stimulation 
involving exogenous FSH (Zielinska et al., 2015). In another human oocyte 
study, Holubcova et al. demonstrated that the majority of clinically discarded 
immature human oocytes are able to undergo anaphase and exhibit consistent 
patterns of spindle assembly and chromosome segregation (Holubcova et al., 
2015). Together, this shows that these oocytes can be valuable tools for 
studying human female meiosis. 
 
In selecting MI oocytes for analysis, only those in which chromosomes were in 
bivalents were included; hence, although 119 immature (GV and MI) oocytes 
were fixed and stained, only a small fraction of these were analysed. Because 
patients often had both normal and abnormal appearing oocytes, both in terms 
of their appearance post-fixation and according to embryologists’ records, these 
abnormalities are unlikely to be linked to the clinical condition of the patients and 
are likely to reflect natural variation. 
 
4.2.  Sister kinetochores in MI oocytes appear to be routinely separated 
in MI 
 
Because distinct kinetochore pairs accounted for the majority of pairs in all 
oocytes from the women who donated to the study, this indicated that separated 
sister kinetochores are an intrinsic feature of human MI oocytes. This is different 
from yeast or mouse in which kinetochores are tightly held together during MI 
(Sarangapani et al., 2014, Kim et al., 2015), and plants in which only the outer 
plates of the kinetochores are fused (Li & Dawe, 2009). The human MI oocytes 
that I observed more closely resembled mouse Meikin-deficient oocytes, in 
which cohesin between sister kinetochores is no longer protected, resulting in 
sister kinetochore separation (Kim et al., 2015). Although a Meikin homologue 
exists in humans and has been visualised at centromeres in pachytene 
spermatocytes by immunofluorescence (Kim et al., 2015), it has yet to be 
89
observed in human oocytes. Future studies will therefore need to investigate 
firstly whether Meikin localises to centromeres/kinetochores in human oocytes, 
and secondly if there are changes in Meikin levels at kinetochores in oocytes of 
different materal ages. An alternative explanation for my result is that the 
antibodies used to detect kinetochores are unable to bind to the region of 
overlap between sister kinetochores, possibly as a result of Meikin or another 
meiotic kinetochore regulator in this location. This could effectively ‘mask’ the 
region and prevent its detection with antibodies. However, given that I observed 
the presence of overlapping kinetochore pairs in addition to separated 
kinetochore pairs, this explanation seems unlikely. 
 
Although distinct pairs accounted for the majority of sister kinetochores, 22.9% 
of kinetochore pairs appeared as single spots, termed ‘overlapping’ pairs. The 
proportions of distinct and overlapping kinetochore pairs varied among oocytes, 
and even among oocytes from the same patient (see Figure 3.5), which may 
indicate that there is centromeric stretching between sister kinetochores, as in 
mitosis (Jaqaman et al., 2010). In mitosis, centromeric stretching occurs as a 
result of forces exerted on chromosomes by k-fibres attached to kinetochores, 
resulting in a push-and-pull motion that helps to align chromosomes at the 
metaphase plate (Skibbens et al., 1993). As the oocytes were fixed during the 
dynamic process of meiotic spindle assembly we are only seeing a snapshot of 
kinetochore arrangement in MI. It has been shown through live-cell imaging that 
the process of spindle assembly is highly protracted and dynamic in human 
oocytes, with chromosomes moving around the spindle region for up to 13 hours 
after GVBD, and then oscillating about the spindle equator up to anaphase 
onset (Holubcova et al., 2015). It is possible that during this period of assembly, 
stretching occurs between sister kinetochores, similar to what occurs in mitosis, 
although the side-by-side arrangement of sisters precludes the possibility of 
push-and-pull dynamics. Finally, the possibility also remains that if imaged at 
higher resolution overlapping pairs may be resolved into two distinct spots, 
because we are currently restricted by the diffraction limit of the light 
microscope. Using super-resolution microscopy, such as 3D structured 
illumination microscopy, may enable resolution of overlapping pairs. 
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It is also possible that the stage of MI at which the oocyte was fixed affects sister 
kinetochore separation. Because of the nature of human oocyte collection, it is 
not possible to precisely ascertain whether the oocytes in this study are in early 
or late stage MI; it is likely that they reflect varying stages of MI. It may be a 
possibility that in early stages of MI, kinetochores are separated, but closer to 
anaphase they become unified. However, as oocytes in this study that appear 
to be in late metaphase (see Figure 3.2d,iv) also have separated kinetochores 
this seems unlikely. High-resolution live-cell imaging is need to answer the 
question of whether sister kinetochore geometry changes during the transition 
from metaphase to anaphase I. 
 
The mean inter-kinetochore distance for all oocytes was 0.69 ± 0.20 µm (mean 
± SD; n = 818 pairs from 27 oocytes), which is greater than that in mice which 
is around 0.4 µm (Kim et al., 2015). My measured value in MI oocytes was closer 
to the inter-kinetochore distances in human and mouse metaphase II-stage 
oocytes (Duncan et al., 2012, Merriman et al., 2013). The second meiotic 
division involves segregation of sister chromatids, so although cohesin remains 
between sister kinetochores, they are not as tightly fused together as they are 
in MI, routinely appearing (in both mouse and human) as two separate spots. 
This indicates that in human MI oocytes, the structures holding sister 
kinetochores together are intrinsically weaker than the fused sister kinetochores 
at MI in other organisms, and hence they more closely resemble sister 
kinetochores at the second meiotic division. 
 
4.3. Internal kinetochore architecture in meiosis I resembles that of 
mitosis 
 
By staining oocytes with markers of the inner plate, outer plate and fibrous 
corona, I was able to show that the entire kinetochore structure appears to be 
separated in MI, as the different markers (CREST, Bub1, Hec1, and CENPE) 
exhibit similar patterns of staining. This suggests that in addition to the inner 
kinetochore that interacts with chromosomes, the regions responsible for 
attachment are also separated, represented by Hec1 and Bub1, which may 
have implications for the ways in which attachments are formed. 
91
 By measuring the inter-kinetochore distance using CENP-E, the outermost 
kinetochore marker, I showed that the degree of separation was similar for the 
inner and outer kinetochore. The slightly increased overall measurement for 
CENP-E in comparison to CREST may reflect a degree of outer kinetochore 
‘swivel’, which has been proposed as a mechanism for kinetochores to be able 
to attach to microtubule fibres at the periphery of the spindle (Smith et al., 2016). 
This difference may also reflect pivoting within the kinetochore, which may be 
necessary for sisters to achieve side-by-side arrangement. 
 
Using these different kinetochore markers, it was possible to measure intra-
kinetochore distances and hence assess the nano-scale architecture of the 
kinetochore architecture. Between MI and MII oocytes, we found only a minimal 
change in kinetochore architecture in the distance from CENP-E to CREST (see 
Figure 3.9), indicating that the internal structure remains unaltered in MI despite 
the side-by-side arrangement of sisters. Further work is needed to determine 
whether the differences are important. The location of CENP-E and Bub1 was 
also consistent with measurements of the same proteins on human mitotic 
kinetochores (Wan et al., 2009), indicating that the outer kinetochore is not 
altered between mitosis and meiosis. However, the distance from the outer 
kinetochore (represented by CENP-E) to the CREST signal was ~50 nm larger 
than that measured in mitotic kinetochores to CENP-A, suggesting that the inner 
kinetochore and/or centromere is either stretched or expanded compared to a 
mitotic kinetochore. Interestingly, such conformational changes have been also 
been reported for mitotic kinetochores when constitutive centromere-associated 
network (CCAN) linkers are depleted (Suzuki et al., 2014). One caveat of this is 
that CREST antisera also recognise CENP-C and CENP-B, which are located 
further into the centromeric chromatin (Earnshaw, 2015). Although other 
antibodies targeted towards a single inner plate protein were tested, none of 
these worked reliably. However, the CREST signal in MI oocytes formed a 
single spot unlike mitotic cells where the signal spreads into the centromere. 
Moreover, CENP-C is positioned distal to CENP-A during mitosis (Suzuki et al., 
2014). Thus, there is support for differences in the organisation of the MI and 
mitotic inner kinetochore/centromere. As the kinetochore-tracking software is 
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currently configured for mitotic cells, in which sister pairs are back-to-back, 
future work will focus on optimising the system for MI. In particular it will be 
informative to compare internal architecture between sister kinetochore pairs to 
determine whether there is a relationship between intra- and inter-kinetochore 
distance. 
 
4.4. Sister kinetochores in metaphase I form dual k-fibre attachments 
 
The ability of sister kinetochore pairs on a homologous chromosome to form 
dual k-fibre attachments indicates that both sisters are functionally active and 
are each capable of acting as independent attachment sites. I speculate that 
the presence of a monotelic population (one sister attached) may represent 
either an immature attachment or the result of an error-correction event. Dual k-
fibre attachments may pose a significant problem for achieving stable co-
orientation (in which both pairs of sister kinetochores are attached to k-fibres 
from their respective spindle poles) as there are potentially twice the number of 
kinetochore-microtubule attachments for the cell to correct. Moreover, the 
method of sensing and correcting these attachments would differ from mitosis, 
because sisters are in a side-by-side arrangement, so there are likely to be 
different tensile forces acting between them in comparison to mitosis. It may be  
a possibility that inter-homologue tension plays a role in meiotic error correction 
rather than inter-kinetochore tension as in mitosis (Figure 4.1). Given that data 
from both mouse and human oocytes indicate that the oocyte’s ability to correct 
unstable kinetochore-microtubule attachments is less efficient than in mitosis 
(Yoshida et al., 2015), the larger number of possible connections along with the 
side-by-side arrangement of sisters may contribute to the increased spindle 
assembly time that is observed in human oocytes (Holubcova et al., 2015). This 
situation is dramatically different to what is known about mouse oocyte MI, in 
which the majority of sister kinetochores are held together by Meikin (Kim et al., 
2015), thus forming a single k-fibre attachment (Kitajima et al., 2011, FitzHarris, 
2012, Touati et al., 2015, Yoshida et al., 2015).  
 
It is also possible that lateral attachments play a role in meiosis. To visualise 
kinetochore-microtubule attachments I used cold-shock treatment which causes 
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a Attachment in mitosis/meiosis II b
k-bre
inter-homologue 
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Sisters attach to k-fibres from opposite 
spindle poles
Sisters form dual k-fibre attachments to k-fibres 
from the same spindle pole
Attachment in meiosis I
Figure 4.1
kinetochore
Figure 4.1. Model for sister kinetochore attachment in MI. (a) Attachment in mitosis/MII, 
in which sister kinetochores attach to k-fibres from opposite poles. Blue arrows represent 
tension between sisters. (b) Proposed model for attachment in MI, in which sister 
kinetochores attach to k-fibres from the same spindle pole. Green arrows represent 
inter-homologue tension.
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microtubules that are not attached in an end-on fashion to depolymerize. In 
mouse, there is evidence that lateral attachments play a role in aligning 
chromosomes at the equator in MI, because end-on attachments are only 
observed at the end of MI, by which stage bivalents are already correctly 
oriented and kinetochores are stretched towards the poles (Brunet et al., 1999). 
The identification of just a small number of end-on attachments in the human 
oocytes included in this study may reflect a possible contribution by lateral 
attachments to achieving bi-orientation. 
 
4.5. Sister kinetochore separation increases with age 
 
Having established that sister kinetochore pairs in MI are separated in human 
oocytes, I next set out to investigate whether there was a relationship between 
female age and kinetochore organisation. The absence of a correlation between 
age and the proportion of distinct sister kinetochore pairs in human MI was 
different to reports in mouse (Chiang et al., 2010). This is likely to reflect the fact 
that in this study population, the vast majority of kinetochores were separated, 
even in the youngest patients. I did find, however, that in the two youngest 
patients (ages 26.2 and 27.7) a relatively high proportion of kinetochores were 
classified as ‘overlapping’. This might suggest that coming apart of sister 
kinetochores happens some years before aneuploidies first begin to arise, 
however without the ability to study oocytes from women at younger ages, this 
cannot be tested.  It is unlikely that oocytes from a younger population will be 
readily obtained, because it is rare for younger patients (< 25 years) to have 
IVF. Other methods of deriving oocytes from younger patients involve growth 
and in vitro maturation of oocytes isolated from resected ovarian tissue; 
however, as these are occasional samples and usually donated by cancer 
patients, there is the possibility that oocytes may have undergone molecular 
damage. Nonetheless, given that the incidence of trisomic pregnancy is similar 
for women in their late teens/early 20s (2–3%) and their early 30s (~5%), we 
would not expect to see a dramatic difference in kinetochore geometry in 
women at earlier ages in comparison with those studied. In contrast, the 
incidence of trisomy for women in their late 30s/early 40s is around 15% 
(Hassold & Hunt, 2001). 
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 Here, I show for the first time in intact human MI oocytes that the entire 
kinetochore structure, from the centromeric inner plate to the fibrous corona, 
comes apart with age (see Figure 4.2). The increase in sister kinetochore 
separation applied to measurements made using both CREST and CENP-E, 
and the increase in inter-kinetochore distance followed a similar trend for both, 
indicating that the entire kinetochore structure comes further apart over time. 
This result is in keeping with findings from monastrol-treated mouse MI oocytes 
(Chiang et al., 2010) and metaphase spreads from mouse and human MII 
oocytes (Duncan et al., 2012, Merriman et al., 2013), which show that aged 
oocytes have sister kinetochores that are further apart. The data is also in 
agreement with that shown by Zielinska et al. in human MI oocytes obtained 
from women undergoing ICSI treatment (Zielinska et al., 2015).  
 
This increase in inter-kinetochore separation in human oocytes is likely to reflect 
a decline in centromeric cohesion with age. This is based on evidence that the 
connection between sister kinetochores in both mitosis and meiosis is at least 
partly dependent on cohesin levels (Eckert et al., 2007, Chiang et al., 2010). In 
mitosis, loss of pericentromeric cohesin causes increased stretching of 
centromeres, indicating that the connection between sisters is elastic (Eckert et 
al., 2007). Support for an age-dependent decline in cohesin has also been 
hinted at in previous studies of human oocytes (Duncan et al., 2012; Tsutsumi 
et al., 2014). However, no studies have so far been able to visualise cohesin 
directly in mature human oocytes, which leaves open the possibility that other 
factors contribute to this effect. In mouse, Meikin loss has been shown to cause 
a similar effect (Kim et al., 2015), so there is also the possibility that loss of a 
meiotic kinetochore regulator also contributes to this effect, however the precise 
identity of this regulator is unclear, particularly as Meikin has not been visualised 
in human oocytes. The precise mechanisms behind a potential decline in 
cohesin are unclear, however it may reflect natural ageing and protein 
degradation. An age-related decline in the meiotic cohesin protector, Sgo2, has 
also been observed in mouse (Lee et al., 2008), so there is also the possibility 
that loss of cohesin protection by shugoshin precedes its decline in human 
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c Mid-30s and older
Figure 4.2
Figure 4.2. Sister kinetochores on bivalents come apart with female age in metaphase 
I stage human oocytes. (a) Schematic of a bivalent in meiosis I, showing sister kinetochores 
(orange) in a side-by-side arrangement and cohesin rings (blue) located along chromosome 
arms and enriched at centromeres. (b) Enlarged representation of meiotic sister kinetochores 
in oocytes from younger women. Kinetochores on sister chromatids form two distinctly 
separate units, each of which is able to form an attachment to a kinetochore-fibre (k-fibre, 
green). (c) In older women, we hypothesise that reduced cohesin, particularly at the 
centromeres, results in sister kinetochores moving apart. This may make it more difficult for 
them to co-ordinate their attachments to k-fibres emanating from the same spindle pole.
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oocytes. Future work to directly visualise cohesin in human oocytes using 
immunofluorescence or live-cell protein markers will be valuable. 
 
The maternal age-dependent change in centromeric chromatin may have 
implications for the formation of stable k-fibre attachments. One report in mouse 
has shown that separated sister kinetochores in aged oocytes do not form more 
unstable attachments than fused pairs, but they do have a slightly increased 
propensity to form merotelic attachments (Shomper et al., 2014), indicating that 
cohesin loss and subsequent separation of sisters does not severely affect 
attachment. However, given that the degree of separation of kinetochores in 
human oocytes is greater than that in mice, it may be a possibility that 
kinetochore pairs with an inter-kinetochore distance beyond a certain threshold 
are prone to mis-attachment, particularly as individual kinetochores within a pair 
act as separate attachment sites. This could be investigated by live-cell imaging. 
 
4.6. Presence of univalents is the most common abnormality in human 
metaphase I oocytes 
 
One of the advantages of studying meiotic chromosomes in situ using high-
resolution microscopy was that it was possible to study chromosome 
configuration in oocytes and to determine whether there were any abnormalities 
or features that predisposed the oocytes to aneuploidy. Given the relatively high 
inter-kinetochore distances that I had measured previously, particularly in older 
oocytes, I expected that single chromatids would be the most likely abnormality, 
particularly as premature separation of sisters has been cited as one of the most 
common causes of aneuploidy. Strikingly, however, of the 17 oocytes for which 
I was able to account for all chromosomes, the presence of univalents was the 
most common abnormality, and no oocytes with single chromatids were 
identified. Recently, two papers have described the phenomenon of bivalent 
conversion into univalents during MI in both mouse and human as a contributor 
to aneuploidy (Ottolini et al., 2015, Sakakibara et al., 2015). These univalents 
often separate their sisters at the first meiotic division (rather than the second), 
hence this type of division is referred to as ‘reverse segregation’. The majority 
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of the bivalents I identified had bi-oriented, and would likely go on to separate 
sister chromatids, which is in keeping with this data. 
 
The average age of the oocytes with abnormal chromosome configurations was 
higher than that of normal oocytes, which is consistent with the known increase 
in aneuploidy with age. Importantly, the ‘abnormal’ oocytes that I identified are 
not aneuploid as they still had the correct numbers of chromosomes and 
kinetochores (hence they would not be picked up in a genetic screen); it is the 
arrangement of the chromosomes that was abnormal and may have made them 
more prone to aneuploidy. Although the abnormally organised oocytes were on 
average older, the average inter-kinetochore distance over the entire oocyte 
was not higher in these oocytes, suggesting that univalents do not arise as a 
result of generalised reduced cohesin. A caveat of this is that I was only able to 
identify 7 abnormal oocytes, therefore more data addressing this point is 
required. It is likely that cohesin had been lost on the univalents that had bi-
oriented, because they had sister kinetochores with separation distances of 
>1.2 µm. However, it is not clear from the data whether this separation would 
precede bi-orientation or occur after it. 
 
4.7. Conclusions and future directions 
 
In summary, my results provide the first insight into MI kinetochore geometry in 
intact human oocytes. I show that the majority of sister kinetochores in MI 
oocytes are separated, which may indicate that the cohesin holding them 
together is inherently weaker than in other species. This raises the question of 
why meiosis in humans is apparently less secure. One possibility is the idea of 
meiotic drive, in which centromere strength (determined by the number of 
microtubule-binding elements) affects the positioning of chromosomes on the 
meiotic spindle and increases the chances of a chromosome being inherited in 
the egg (Henikoff et al., 2001, Chmátal et al., 2014). It is possible that both sister 
kinetochores retain their ability to bind for this reason, and the apparent absence 
of a regulator such as Meikin may facilitate the formation of stronger 
attachments. 
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The overall structure and architecture of individual kinetochores appears to 
resemble that of mitosis and meiosis II, in which sister kinetochores attach to 
spindle fibres from opposite poles, indicating that kinetochores do not undergo 
internal structural changes prior to meiosis I. I show that the degree of 
separation increases with age, consistent with the profile of maternal age-
related aneuploidies in women. I also show that, as well as the chromatin-
associated inner plate, the outer microtubule-interacting regions of the 
kinetochore are also separated, which enables sister kinetochores to act as 
individual attachment sites. This results in the formation of dual k-fibre 
attachments. Since both sister kinetochores are able to form k-fibre 
attachments, stable bi-orientation may be more difficult to achieve, which may 
be exacerbated by increasing inter-kinetochore distances with increasing 
maternal age. These features of kinetochores in MI oocytes may shed light on 
the particularly high incidence of chromosome segregation errors at first meiosis 
in human oocytes. 
 
An important aspect of future research will be to study kinetochore dynamics 
during MI using high-resolution live-cell imaging (see Appendix A). This will 
enable us to answer many key questions about meiosis I that have been raised 
by these findings, including whether increased inter-kinetochore distance 
predisposes to erroneous kinetochore-microtubule attachments, how sister 
kinetochore dynamics differ from mitosis/MII, and whether lateral attachments 
play a role in MI. In the first human oocyte live-cell imaging paper, Holubcova et 
al. showed that human oocytes form many erroneous attachments during the 
spindle assembly process in MI, although the imaging was not of high enough 
resolution to resolve individual kinetochores within pairs (Holubcova et al., 
2015). Other studies have used kinetochore tracking to study the movement of 
kinetochore pairs in mouse MI oocytes (Kitajima et al., 2011), an approach that 
would be valuable in human oocytes if individual sisters could be resolved, as 
this would enable us to study their behaviour during this highly error-prone 
division. 
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Appendix A. Establishing a live-cell 
imaging platform for studying human 
oocytes 
 
A1.  Introduction 
 
In addition to fixed-cell data, I aimed to acquire information from live oocytes by 
imaging them as they progressed through the first and second meiotic divisions. 
Through live-cell imaging, it would be possible to answer many questions that 
fixed cell analysis cannot. In particular, I wanted to investigate whether oocytes 
with separated sister kinetochores were able to divide normally and whether an 
increased separation distance made oocytes more prone to errors at 
cytokinesis. Described here are initial attempts to establish a live cell imaging 
platform for human eggs. 
 
Live-cell imaging in human oocytes presents several technical challenges. 
Firstly, there is the limited availability of the material and its acquisition which is 
highly dependent on clinical variables. Secondly, human oocytes are highly 
sensitive to small changes in temperature and pH (Pickering et al., 1990, Dale 
et al., 1998). Nonetheless, Holubcova et al. were able to establish the first 
platform for live-cell imaging in human oocytes using mRNA microinjection to 
visualise chromosomes and microtubules (Holubcova et al., 2015). I aimed to 
use a similar approach to further study kinetochore organisation and behaviour 
during meiosis. A particular goal was to establish a method of studying oocytes 
that would enable high-resolution visualisation of the kinetochores during MI, so 
that we could study their behaviour during this error-prone division. 
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A2. Methods 
 
A2.1. Molecular Biology 
 
A.2.1.1. Plasmids 
 
The following plasmids were used in in this project: 
 
Table A2.1. Plasmids 
Plasmid name Encoded 
protein 
Resistance 
marker 
Source Use 
pGEMHE-H2B-mRGFP Histone 2B Ampicillin Schuh & 
Ellenberg, 2007 
Microinjection 
pGEMHE-Mad2-mEGFP Mad2 Ampicillin Kitajima et al., 
2007 
Plasmid 
production 
Ndc80-mCherry Ndc80 Kanamycin Smith et al., 2016 Plasmid 
production 
Ndc80-mEGFP Ndc80 Ampicillin This work Microinjection 
 
A2.1.2. Production of Ndc80-EGFP construct 
 
An Ndc80-EGFP construct was prepared using PCR-based molecular cloning. 
A Mad2-EGFP plasmid construct was used as the vector plasmid and an 
Ndc80-tagRFP plasmid (McAinsh lab) for the Ndc80 insert. Mad2-EGFP was 
digested using NcoI and NheI. The Ndc80 sequence was isolated using PCR 
(conditions in Table A2.2) with forward and reverse primers incorporating the 
restriction enzyme sites and targeted to the start of Ndc80 and the end of the 
linker region respectively (see Table A2.3). The final product was purified using 
a gel extraction kit (Qiagen). For ligation, the concentration of the insert and 
vector were estimated in Nanodrop. A 3:1 ratio of vector to insert was used. 
Ligation was undertaken for 45 min at room temperature. Following ligation, the 
total volume of the ligation mix was added to DH5-α competent cells. These 
were plated onto ampicillin plates and left overnight at 37ºC. A miniprep 
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procedure was used to isolate plasmids. The final plasmid construct was 
confirmed by sequencing (SourceBioscience; see Table A2.4).  
 
Table A2.2. PCR conditions (30 cycles) 
 Temp (°C) Time 
Initial denaturation 98 30 s 
Denaturation 98 10 s 
Annealing 65 30 s 
Extension 72 1 min 
Final extension 72 5 min 
Hold 4  
 
  
Table A2.3. Primers used for PCR of Ndc80 insert 
Primer Sequence 
Forward gatccgctagcatgaagcgcagttcagtttc 
             NheI site 
Reverse cagacccatggatcccgggtggaacagaa 
             NcoI site 
  
 
Table A2.4. Primers for sequencing 
Primer Sequence (5’ to 3’) Source 
EGFP Nrev cgtcgccgtccagctcgaccag SourceBioscience 
(stock) 
T7 promoter taatacgactcactataggg SourceBioscience 
(stock) 
Ndc80 forward atccgctagcatgaagcgcagttcagt  Smith et al., 2016 
Ndc80 reverse ggatcccgggtggaacagaacttccag Smith et al., 2016 
 
A2.1.3. Production of messenger RNA 
 
A T7 MMESSAGE kit (Ambion) was used to transcribe mRNA from plasmids. 
The resulting mRNA was purified using a RNA elution kit (Qiagen) which 
excludes unincorporated nucleotides. Electrophoresis was used to determine 
the size and purity of the final product. For RNA electrophoresis, a 1% gel was 
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prepared using RNase-free agarose (Seakem). Approximately 0.5 µg of mRNA 
was mixed with 2X loading buffer containing foramide (Ambion). Prior to running 
on the gel, the mRNA and loading buffer were incubated for 10 min at 70ºC. 
The mRNA was then run at 120 mV for 20 min alongside an 0.5–10 kb RNA 
ladder (Invitrogen) which had undergone the same pre-treatment steps as the 
mRNA. The concentration of mRNA was estimated in Nanodrop 2000. 
 
A2.2. Human oocytes 
 
A2.2.1. Microinjection of human oocytes 
 
Following collection (as described in main Methods section), oocytes were 
transferred into pre-equilibriated G-MOPS (Vitrolife) media with 5% human 
serum albumin (Vitrolife). They were transported from the IVF clinic at University 
Hospitals Coventry & Warwickshire to the Centre for Mechanochemical Cell 
Biology, University of Warwick, in a 37ºC transport incubator, where they were 
moved into fresh media and placed in a 37ºC incubator with 5% CO2. Oocytes 
were microinjected on a heated stage using a clinical standard microinjector 
equipped with injection and holding pipettes (The Pipette Company, Australia). 
Between 15–20 pl of 1 µg/µl mRNA was injected into each oocyte. Following 
mRNA injection, oocytes were incubated for at least 4 hours following micro-
injection. For imaging, oocytes were placed in a ~50 µl drop of media overlaid 
with sterile mineral oil. In total, 11 GV oocytes (acquired on the day of collection 
from the patient) and 36 MII oocytes (acquired on the day following collection) 
were used. 
 
A2.2.2. SiR-DNA treatment 
 
Following microinjection and prior to imaging, oocytes were moved into G-
MOPS containing 2 µg/µl SiR-DNA (Spirochrome), a cell-permeable DNA 
probe, and the efflux pump inhibitor verapamil (1 µg/µl). Incubation times of 30  
min, 1 hour and 2 hours were tested. As there were no differences between the 
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oocytes treated for 30 min compared to those treated for longer periods, an 
incubation time of 30 min was used for subsequent treatments. 
 
A2.2.3. Imaging 
 
Initial imaging was performed on a Zeiss LSM 510 fluorescent confocal 
microscope using a 63x oil immersion objective. Live-cell imaging was 
performed on a Deltavision microscope (Applied Precision, LLC) with a 60x 1.4 
NA oil immersion objective. For overnight time-lapse, 11 z-sections spaced 2 
µm apart were taken every 15 min over 11 hours.  
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A3. Preliminary Results 
 
Initial imaging of oocytes micro-injected with mRNA encoding H2B-mRFP and 
Ndc80-EGFP revealed fluorescent patches in all oocytes, including ones that 
had not been injected with mRNA. These were visible when imaging at 488 and 
561 wavelengths, suggesting that the patches were auto-fluorescent (Figure 
A1). These patches are likely to correspond to lipofuscin bodies. Lipofuscin 
bodies (>5 μm) have been observed previously in live oocytes and embryos of 
all stages and do not appear to be associated with cell death or maternal age, 
however larger lipofuscin bodies (>5 μm) have been associated with reduced 
IVF fertilisation rates (Otsuki et al., 2007). 
 
In one micro-injected GV-stage oocyte we observed fluorescent structures in 
the 561 (red) channel, but not under the 488 wavelength, indicating that these 
were not lipofuscin bodies, and that mRNA encoding H2B-mRFP had been 
translated and incorporated (Figure A2). During overnight time-lapse imaging, 
the fluorescent structure did not move, which may indicate oocyte cell death. 
 
SiR (silicon–rhodamine) DNA, a cell-permeable marker of DNA that displays 
minimal toxicity and is compatible with high-resolution live-cell imaging 
(Lukinavicius et al., 2015), was also used to stain oocytes The SiR-DNA was 
tested by incubating oocytes for 30 minutes, or 1, 2 or 3 hours in media 
containing SiR-DNA prior to imaging and after mRNA microinjection. In one GV 
oocyte, it was possible to see fluorescent structures that may have 
corresponded to DNA (Figure A3). However, as before, these structures did not 
move or display any dynamic behaviour during overnight imaging of this oocyte. 
In all cases in which the SiR-DNA was utilised in oocytes donated from IVF 
cycles, it was possible to see chromatin from the sperm with which the oocytes 
had been previously incubated, indicating that the SiR-DNA treatment was 
working, however oocyte chromosomes were not visible. To visualise the stain, 
we also incubated oocytes with verapamil, an efflux pump inhibitor that can 
improve the SiR-DNA signal, however this did not enable visualisation of oocyte 
chromosomes.  
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Figure A1. Auto-fluorescent lipofuscin bodies in oocytes. Oocytes imaged on a Zeiss 
LSM 510. (a–c) Oocytes injected with mRNA encoding H2B-mRFP and Ndc80-EGFP. (d) 
Atretic oocyte which was not injected, also showing the presence of lipofuscin bodies.
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Figure A2. Timelapse of a germinal vesicle (GV) stage oocyte microinjected with 
messenger RNA encoding H2B-mRFP and Ndc80-EGFP. (a) The presence of 
fluorescence in the 561 channel indicates that the mRNA encoding H2B-mRFP was 
translated. There is no fluorescence in the 488 channel, indicating that this is unlikely to be 
auto-fluorescence. (b) Enlarged view of the fluorescent structure in the 561 channel. Time is 
given in hours and minutes. Images were acquired every 15 min over a period of 11 hours.
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Figure A3. Oocyte stained with SiR-DNA, a cell-permeable live-cell DNA stain that 
contains a far-red fluorogenic marker. This germinal vesicle (GV) stage oocyte was 
incubated with SiR-DNA for 30 mins, after which far-red fluorescent structures could be seen 
within the GV that are likely to correspond to oocyte DNA. The structures did not move after 
overnight imaging, indicating possible cell death.
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A4. Discussion 
 
The experiments described here detail efforts to establish high-resolution 
imaging in oocytes. In the majority of cases, it was not possible to visualise 
chromosomes in the oocytes. The nature of the experiments required oocytes 
to be briefly in environments in which temperature and CO2 levels could not be 
strictly controlled, e.g. during microinjection and during oocyte transfer into 
different solutions. As numerous studies have reported, exposure of oocytes to 
room temperature for short periods of time (between 10–30 minutes) can cause 
meiotic spindle disruption and chromosome scattering from which few oocytes 
can recover (Pickering et al., 1990, Wang et al., 2001). It is therefore possible 
that oocytes had undergone spindle disruption which may have disturbed the 
chromosomes and prevented incorporation of proteins translated from mRNA. 
 
Another factor that is likely to have impacted the methods is the quality and 
availability of the material. For live-cell imaging, GV oocytes that can be donated 
to research on the day of collection from the patient are the optimal material, 
however these samples are limited and just account for approximately one fifth 
of the oocytes used for this work (see Methods for details). The remainder were 
MII oocytes that became available to research on the day following collection, 
after overnight incubation. 
 
Although use of the SiR-DNA stain enabled visualisation of sperm 
chromosomes, in no oocytes could we see oocyte chromosomes. It is possible 
that oocyte chromosomes were not visible when using SiR-DNA due to inability 
of the stain to reach the chromosomes. Unlike in spermatozoa, in oocytes the 
stain must penetrate through the zona pellucida and a vast amount of 
cytoplasmic material to reach the chromosomes. It is likely that further 
optimisation when using this stain in human oocytes is required. 
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Unique geometry of sister kinetochores in human oocytes during
meiosis I may explain maternal age-associated increases in
chromosomal abnormalities
Jessica Patel1, Seang Lin Tan2, Geraldine M. Hartshorne1,3 and Andrew D. McAinsh4,*
ABSTRACT
The first meiotic division in human oocytes is highly error-prone and
contributes to the uniquely high incidence of aneuploidy observed in
human pregnancies. A successful meiosis I (MI) division entails
separation of homologous chromosome pairs and co-segregation of
sister chromatids. For this to happen, sister kinetochores must form
attachments to spindle kinetochore-fibres emanating from the same
pole. In mouse and budding yeast, sister kinetochores remain closely
associated with each other during MI, enabling them to act as a single
unified structure. However, whether this arrangement also applies in
human meiosis I oocytes was unclear. In this study, we perform high-
resolution imaging of over 1900 kinetochores in human oocytes, to
examine the geometry and architecture of the human meiotic
kinetochore. We reveal that sister kinetochores in MI are not
physically fused, and instead individual kinetochores within a pair
are capable of forming independent attachments to spindle k-fibres.
Notably, with increasing female age, the separation between
kinetochores increases, suggesting a degradation of centromeric
cohesion and/or changes in kinetochore architecture. Our data
suggest that the differential arrangement of sister kinetochores and
dual k-fibre attachments may explain the high proportion of unstable
attachments that form in MI and thus indicate why human oocytes are
prone to aneuploidy, particularly with increasing maternal age.
KEY WORDS: Aneuploidy, Chromosome segregation, Human,
Kinetochore, Meiosis, Oocyte
INTRODUCTION
The chances of a chromosomally abnormal pregnancy increase
dramatically in humans with advancing maternal age (Nagaoka
et al., 2012). Most meiosis-derived aneuploidies in early embryos
originate from the first meiotic division of the oocyte, which is
particularly error-prone (Hassold and Hunt, 2001). During the first
meiotic division, sister chromatids segregate together, which
requires kinetochores on sister chromatids to form attachments
to spindle kinetochore-fibres (k-fibres) from the same pole of
the spindle. This is in contrast to mitosis and meiosis II (MII),
in which sisters form attachments to opposite spindle poles. In
meiosis I (MI), therefore, it follows that the arrangement of sister
kinetochores will be different; a side-by-side rather than the usual
‘back-to-back’ arrangement is likely (Watanabe, 2012). Of the
meiotic sister kinetochores that have been studied so far, in maize,
yeast and mouse, all appear to be in close association with each
other, appearing as a single coherent unit. In maize and yeast,
there is evidence that sisters are physically tethered: in maize, a
Mis12-Ndc80 bridge links sisters (Li and Dawe, 2009); and in
budding yeast, the monopolin complex performs a similar cross-
linking role (Corbett et al., 2010; Sarangapani et al., 2014). In
mouse oocytes, the meiotic regulator protein Meikin is important
for keeping sister kinetochores together; loss of Meikin results in
separation of sister kinetochores from a single unit into two
distinct foci (Kim et al., 2015). A similar effect occurs in oocytes
of aged mice, which is likely to reflect a loss of centromeric
cohesin (Chiang et al., 2010). In human oocytes, the structure of
the meiotic kinetochore is largely unknown with an initial study
suggesting that inter-sister distances may increase in aged human
oocytes (Sakakibara et al., 2015). It possible that an altered
kinetochore geometry contributes to the features of human MI that
differ from other species including the much higher incidence of
aneuploidy and the protracted spindle assembly period (Holubcova
et al., 2015).
RESULTS
To investigate the geometry of sister kinetochores in MI, we
examined sister kinetochore pairs in MI oocytes from women
undergoing assisted reproduction following ovarian stimulation
(Table S1). Our knowledge of mammalian meiosis is mostly based
on mouse oocytes, because immature human oocytes available for
research are typically only those that are not suitable for use in the
donating patient’s fertility treatment. However, it has been shown
that the majority of clinically discarded immature human oocytes
are able to undergo anaphase and exhibit consistent patterns of
spindle assembly and chromosome segregation (Holubcova et al.,
2015), highlighting their usefulness as tools for understanding
human female meiosis. We therefore used human oocytes that
had not yet completed the first meiotic division, confirmed by
the absence of a polar body (Fig. 1A). Oocytes were fixed in
paraformaldehyde and immunofluorescence was performed with
CREST antisera to mark the centromere/inner kinetochore and
DAPI to visualise chromosomes. High-resolution 3D image stacks
(250×50 nm z-sections) of the meiotic chromosomes and
kinetochores were collected using spinning-disk confocal
microscopy. The number of CREST foci within these oocytes was
considerably higher than 46, the number of kinetochores expected
in a euploid MI oocyte in which all sister kinetochores are fused.
This therefore raised the possibility that sister kinetochores are not
fused. To investigate this, we marked sister kinetochore pairs in 3DReceived 3 December 2015; Accepted 22 December 2015
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image stacks, then classified these pairs on the basis of whether they
appeared as ‘distinct’ pairs (two distinct spots) or ‘overlapping’
pairs (a single spot) (Fig. 1B). To confirm identity of pairs, we used
surface rendering in three dimensions, which made it possible to
identify individual bivalents associated with two sister kinetochore
pairs (Fig. 1C). Classification was performed using z-projection
images incorporating 20 z-sections (1.0 µm) centred about marked
pairs (Fig. S1).
The majority (78%) of sister kinetochore pairs were identified
as being distinct, with an average of 35 (range: 22–44) distinct
pairs per oocyte (n=22 oocytes, Fig. 1D). A euploid oocyte has 46
kinetochore pairs in total, so distinct pairs account for the majority
of kinetochore pairs in the population of oocytes we studied. The
remaining 22% of sister kinetochore pairs were classified as
overlapping, with an average of 10 (range: 0–22) overlapping pairs
per oocyte. There were no differences in oocytes from women
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Fig. 1. Sister kinetochores in meiosis I (MI) human
oocytes are not fused. (A) Left panel: fixed human
oocyte in MI. Dotted lines mark zona pellucida, oocyte
and chromosomes (60× objective; scale bar=5 µm).
Right panel: maximum intensity projection of the
meiotic chromosomes within this same oocyte (100×
objective; scale bar=2 µm). (B) Enlarged bivalents
outlined in A, right panel, in which two kinetochore pairs
per bivalent can be seen. Further enlargements of
representative examples of distinct and overlapping
sister kinetochore pairs are shown. Scale bars=0.5 µm.
(C) 3D reconstruction of the kinetochores and
chromosomes in an MI oocyte by surface rendering.
To the right are two examples of individual bivalents
showing the two categories of kinetochore pairs.
(D) Mean±s.d. number of kinetochores within each
oocyte, classified according to whether kinetochores
were within distinct or overlapping pairs (n=1944
kinetochores from 22 oocytes). For a small number of
kinetochores, sister kinetochores were so far apart
(>1.5 µm) that they were classified as ‘unpaired’.
A small number of foci could not be reliably identified
as being either single kinetochores or overlapping pairs
and these were classified as ‘unclear’. (E) Proportion of
distinct and overlapping pairs for each individual
oocyte. Asterisks indicate oocytes from women with no
known fertility issues. (F) Inter-kinetochore distance as
measured from the CREST signal (n=579 sister
kinetochore pairs from 19 oocytes). Box plot represents
interquartile range (IQR); whiskers extend to most
extreme value within 1.5×IQR.
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with no known fertility issues, i.e. couples with male factor
infertility (marked with asterisks in Fig. 1E; see also Table S1),
indicating that these observations are unlikely to result from
infertility issues. To quantify the degree of separation, we used
CREST signals to measure the inter-kinetochore distance between
distinct sister pairs (see Fig. 1C, upper right panel). Distances
were measured in 3D using the peak intensity of the kinetochore
signal to mark individual kinetochore positions. The median inter-
kinetochore distance was 0.69±0.21 µm (median±s.d.; n=579 pairs
from 19 oocytes; Fig. 1F).
The kinetochore is a large multi-subunit structure, consisting
of an inner plate, outer plate and fibrous corona (Chan et al., 2005).
A possible arrangement for human meiotic sister kinetochores may
involve distinct inner plates (as we observed through CREST
staining) but fused outer plates, an architecture observed in maize
MI (Li and Dawe, 2009). As the outer plate is involved in formation
of stable k-fibre attachments (Sundin et al., 2011), this model would
enable sisters to form a single k-fibre attachment between them to
ensure co-segregation. To test whether this model applies in
humans, we used immunofluorescence to label the inner plate/
centromere (CREST), outer plate (Bub1) and the fibrous corona
(CENP-E) in oocytes (Wan et al., 2009; Earnshaw, 2015).
Strikingly, the outer kinetochore markers also appeared separated
in MI sister kinetochore pairs (Fig. 2A), demonstrating that the
entire kinetochore structure is distinct. By fixing whole intact
oocytes, it was also possible visualise the side-by-side arrangement
of sister kinetochores, and show that the inner kinetochore (CREST)
is located towards the centromeric chromatin, with the outer
kinetochore (CENP-E) facing outwards (Fig. 2B,C). This indicates
that the overall kinetochore architecture appears to be similar to that
found in mitosis. Together, this data indicates that human MI sister
kinetochores do not appear to be fused.
One possibility is that in human MI, only one sister kinetochore
is active and the other is shut off. To test this, we examined
kinetochore-microtubule attachments in oocytes subjected to cold-
shock treatment, which destabilises microtubules that are not
attached to kinetochores in an end-on configuration. In a small
number of cases (n=5 sister kinetochore pairs from three oocytes),
we observed pairs in which one kinetochore was attached to a
k-fibre but its sister was not. However, more frequently, we noted
the presence of kinetochore pairs with dual k-fibre attachments
(n=20), in which each sister within the pair was attached to a distinct
k-fibre (Fig. 3). These attachments were observed in both distinct
(18/20) and overlapping (2/20) kinetochore pairs, thereby providing
evidence that homologous chromosomes can connect to the meiotic
spindle via two independent attachment sites.
During the first meiotic division, unlike in mitosis, cohesin is
protected between sister kinetochores to ensure co-segregation
(Kitajima et al., 2004). Cohesin loss over time has been the focus
of many studies investigating maternal age-related aneuploidy
(Jessberger, 2012). Therefore, we tested whether the high
proportion of distinct pairs that we observed was associated with
patient age. We found that there was no significant correlation
between age and proportion of distinct pairs in our sample (Fig. 4A),
although in the two youngest patients (26 and 27 years) just over 50%
were separated, suggesting there may be a mild age-related effect.
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Fig. 2. Inner/outer/corona regions of each sister kinetochore are distinct. (A) Chromosomes in a meiosis I (MI) oocyte stained with CREST antisera
(kinetochore inner plate/centromere), anti-Bub1 antibodies (kinetochore outer plate) and anti-CENP-E antibodies (fibrous corona). Image is a maximum intensity
projection incorporating 100×50 nm z-sections (5.0 µm). Inset shows a distinct sister kinetochore pair. Scale bar=2 µm. (B) Left upper and lower panels show a
maximum intensity projection (100 × 50 nm z-sections) of chromosomes in an MI oocyte stained for CREST, CENP-E and DAPI. Lower-left panel shows the
kinetochores only, in which CREST is clearly located towards the centromeric chromatin, with CENP-E on the outside. A projection (20 × 50 nm z-sections) of the
outlined bivalent chromosome is shown in the middle and right panels, in which the arrangement of the inner (CREST, red) and outer (CENP-E, green)
kinetochore can be seen more clearly. The bottom right panel depicts the surface rendered bivalent. Scale bars=2 µm (left panel), 0.5 µm (right panel).
(C) Schematic showing the arrangement of sister kinetochores in mitosis (back-to-back) and the proposed arrangement in meiosis I (side-by-side).
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However, we noticed that in oocytes from older women, sister
kinetochore pairs appeared to be further apart than in oocytes from
younger patients (Fig. 4B). We therefore revisited our inter-
kinetochore distance measurements and examined them in the
context of age. Using both CREST and CENP-E as kinetochore
markers, we found that there was a gradual increase in inter-
kinetochore distance over the entire kinetochore structure with age
(Fig. 4C). The subset of oocytes fromwomen with no known fertility
issues (n=4; labelled in Fig. 4C and see Table S1) also fit this trend
suggesting this is part of the normal ageing process. As themajority of
aneuploidies in human embryos arise when a woman is in her mid to
late thirties (Hassold and Hunt, 2001), we compared oocytes from
women under 33 years of age (age range: 26.2–32.4 years) with
oocytes from women over 38 years of age (age range: 38.4–
40.7 years). We found a significant increase in inter-kinetochore
distance from a mean of 0.65±0.20 µm (n=214 pairs from seven
oocytes) in women under 33 to 0.79±0.21 µm (n=216 pairs from
seven oocytes) in those over 38 (P<0.0001, unpaired t-test) (Fig. 4D).
We also compared these oocytes (under 33 years) with oocytes from
women in their mid-thirties, for which the mean inter-kinetochore
distance was 0.69±0.19 (n=149 pairs from five oocytes; age range:
34.9–35.1).We found that the difference in inter-kinetochore distance
was not significant between the two younger groups of patients, but it
was significant when comparing women in their mid-thirties with
those over 38 years of age (P<0.0001). This is in keeping with the
observed increase in MI-derived aneuploidy in oocytes from women
in their mid to late thirties.
DISCUSSION
In this study, we aimed to characterise the geometry of the meiotic
kinetochore in human MI oocytes. Because distinct kinetochore pairs
accounted for the majority of pairs in all oocytes from all women who
donated to the study, this indicated to us that separated sister
kinetochores are an intrinsic feature of human MI oocytes. This is
different from yeast or mouse in which kinetochores are tightly held
together during MI (Sarangapani et al., 2014; Kim et al., 2015), and
plants in which only the outer plates of the kinetochores are fused (Li
and Dawe, 2009). The human MI oocytes that we observed more
closely resembled mouse Meikin-deficient oocytes, in which cohesin
between sister kinetochores is no longer protected resulting in sister
kinetochore separation (Kim et al., 2015). The variation in proportions
of distinct and overlapping kinetochore pairs, even among oocytes
from the same patient, may indicate a degree of compliance between
sister kinetochores, as in mitosis (Jaqaman et al., 2010).
The ability of sister kinetochore pairs on a homologous
chromosome to form dual k-fibre attachments indicates that both
sisters are functionally active and are each capable of acting as
independent attachment sites. We speculate that the presence of
a monotelic population (one sister attached) may represent either
an immature attachment or the result of an error-correction event.
Clearly, the presence of four independent attachment sites could pose
a significant problem for achieving stable co-orientation (both pairs of
sister kinetochores attached to k-fibres from their respective spindle
poles), particularly as the sister kinetochores move further apart.
Furthermore, it means that there are potentially twice the number of
kinetochore-microtubule attachments for the cell to correct. Given
that data from both mouse and human oocytes indicate that the
oocyte’s ability to correct unstable kinetochore-microtubule
attachments is less efficient than in mitosis (Yoshida et al., 2015),
the larger number of possible connections may contribute to the
increased spindle assembly time that is observed in human oocytes
(Holubcova et al., 2015). This situation is dramatically different to
what is known aboutmouse oocyteMI, in which themajority of sister
kinetochores are held together by Meikin (Kim et al., 2015), thus
forming a single k-fibre attachment (Kitajima et al., 2011; FitzHarris,
2012; Touati et al., 2015; Yoshida et al., 2015).
The absence of a correlation between age and the proportion of
separated sister kinetochore pairs in human MI is different to what
has been reported inmouseMI (Chiang et al., 2010). This is likely to
reflect the fact that in our study population, the vast majority of
dual k-fibre attachments
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Fig. 3. Sister kinetochore pairs in meiosis I (MI) engage with independent kinetochore-fibres. (A) Two MI human oocyte spindles stained for microtubules
(anti-α-tubulin) and kinetochores (CREST antisera) after cold-shock treatment. (B) Enlarged z-sections of the six different kinetochore pairs outlined by white
boxes in A, with dual and monotelic attachments as indicated. Three z-sections from the stack are shown for each pair, at –200 nm, 0 nm and +200 nm. Scale
bar=2 µm.
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kinetochores are separated, even in the youngest patients. No
samples below 26 years of age were available because it is
extremely rare for younger patients to have IVF. Nevertheless, the
incidence of trisomic pregnancy is similar for women in their late
teens/early twenties (2–3%) and their early thirties (∼5%), so we
would not expect to see a dramatic difference in kinetochore
geometry in women at earlier ages than those studied. In
comparison, the incidence of trisomy for women in their late
thirties/early forties is around 15% (Hassold and Hunt, 2001).
We show here that in intact human MI oocytes the entire
kinetochore inner-to-outer-to-corona structure comes apart with
age. This is in keeping with findings from monastrol-treated mouse
MI oocytes (Chiang et al., 2010) and metaphase spreads from mouse
and humanMII oocytes (Merriman et al., 2013; Duncan et al., 2012).
The maternal age-dependent change in centromeric chromatin may
have implications for the formation of stable k-fibre attachments. One
report in mouse has shown that separated sister kinetochores in aged
oocytes do not form more unstable attachments than fused pairs, but
they do have a slightly increased propensity to form merotelic
attachments (Shomper et al., 2014), indicating that cohesin loss and
subsequent separation of sisters does not severely affect attachment.
However, given that the degree of separation of kinetochores in
human oocytes is greater than that in mice, it may be a possibility that
kinetochore pairs with an inter-kinetochore distance beyond a certain
threshold are prone to mis-attachment, particularly as individual
kinetochores within a pair act as separate attachment sites. It is also
important to bear in mind that our results are only indicative of
cohesin loss, and without direct study of cohesin there is the
possibility that these changes in kinetochore geometry could be
caused by other factors, such as changes in kinetochore or chromatin
structure or microtubule-pulling forces.
In summary, our results provide a detailed insight into MI
kinetochore geometry in intact human oocytes. We show that the
majority of sister kinetochores in MI oocytes are separate, and that
the degree of separation increases with age, consistent with the
profile of maternal age-related aneuploidies in women. We also
show that, as well as the chromatin-associated inner plate, the outer
microtubule-interacting regions of the kinetochore are also separate,
which facilitates the sister kinetochores acting as individual
attachment sites. Since both sister kinetochores are able to form
k-fibre attachments, stable bi-orientation may be more difficult to
achieve, which may be exacerbated by increasing inter-kinetochore
distances with increasing maternal age. These features of
kinetochores in MI oocytes may shed light on the particularly
high incidence of chromosome segregation errors at first meiosis in
human oocytes.
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Fig. 4. Inter-kinetochore distance between sister kinetochores in meiosis I increases with maternal age. (A) Relationship between proportion of distinct
pairs per oocyte and female age (n=22 oocytes). (B) Comparison of oocyte chromosomes from a 26-year-old patient and a 38-year-old patient, showing increased
inter-kinetochore distance with kinetochores marked with CREST antisera (red) and anti-CENP-E antibodies (green). Inset: representative example of a distinct
kinetochore pair from each oocyte. Scale bars=2 µm. (C) Increasing inter-kinetochore distance with female age. Distance was measured in 3D from image
stacks of kinetochore pairs, using CREST antisera (left plot) and anti-CENP-E antibodies (right plot) to mark the inner and outer regions of the kinetochores
respectively. Patients with no known fertility problems (n=4) are marked in yellow. Patient numbers correspond to those shown in Table S1. R=linear correlation
coefficient. (D) Comparison of inter-kinetochore distance between women under 33 years of age with women over 38 (P<0.0001, unpaired t-test) for CREST and
CENP-E. Box plots represent interquartile range (IQR); whiskers extend to most extreme value within 1.5×IQR. The number of oocytes in each group is shown
beneath each plot, with the total number of measurements in brackets.
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MATERIALS AND METHODS
Donation of human oocytes to research
Approval for the project was granted by the NHS Research Ethics
Committee (04/Q2802/26) and the Human Fertilisation and Embryology
Authority (HFEA; Research Licence RO155). Informed consent for
donation of oocytes to research was provided by patients undergoing
in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) at the
Centre for Reproductive Medicine, University Hospitals Coventry and
Warwickshire NHS Trust. All oocytes used for research were unsuitable for
the patient’s treatment and would otherwise have been discarded. For
purposes of selection for research use, oocytes were presumed to be in MI if
neither a germinal vesicle nucleus nor polar bodies were visible by light
microscopy. This initial clinical assessment was further informed by
detailed analysis of chromosomes in the course of the research.
Whole oocyte fixation
Whole oocytes were fixed and stained using a method previously described
(Riris et al., 2013). Briefly, oocytes were washed in PHEM buffer (60 mM
PIPES, 25 mM HEPES, 10 mM EGTA, 4 mMMgSO4.7H2O; pH 6.9) with
0.25% Triton X-100, then fixed in 3.7% paraformaldehyde in PHEM for
30 min. Following fixation, they were washed in PBB (0.5% BSA in PBS),
permeabilised with 0.25% Triton X-100 in PBS for 15 min, then transferred
to a blocking solution (3% BSA in PBS with 0.05% Tween-20) where they
were stored at 4°C overnight. For cold shock treatment, oocytes were placed
in ice-cold media for 1 min immediately upon receipt, then fixation and
immunofluorescence were performed as described.
Immunofluorescence
Immunofluorescence was performed using a method previously described
(Riris et al., 2013). Oocytes were incubated at 37°C for 1 h with primary
antibodies diluted in blocking solution, followed by a 15 min wash in PBB
with 0.05% Tween-20, then incubation with secondary antibodies for 1 h,
followed by a final wash step. Primary antibodies included: anti-centromere
antibody derived from human CREST serum (1:50; Antibodies
Incorporated, Davis, CA, USA), rabbit anti-CENP-E (1:200; Meraldi
et al., 2004) mouse monoclonal antibody against α-tubulin (1:200; T6074
Sigma-Aldrich, St Louis, MO, USA), mouse monoclonal antibody to Hec1
9G3 (1:50; ab3613 Abcam, Cambridge, UK) and mouse monoclonal
antibody to Bub1 (1:50; Meraldi et al., 2004). Secondary tagged antibodies
were diluted 1:200 and included anti-mouse Alexa Fluor 488®, anti-rabbit
Alexa 594® and anti-human Alexa 647® (Stratech, Suffolk, UK). Oocytes
were mounted in ProLong® Gold Antifade Mountant with DAPI
(Invitrogen, Carlsbad, CA, USA) for detection of chromosomes.
Imaging
All imaging was performed on an UltraView spinning-disk confocal
microscope (Perkin Elmer, Waltham, MA, USA). 3D image stacks were
collected using a 60× NA1.4 (100×1 μm z-sections) and 100× NA1.4
(250×50 nm z-sections) oil objective. Images were acquired using Volocity
software.
Image and data analysis
Images were deconvolved using Huygens X11 (Scientific Volume Imaging
B. V., Hilversum, Netherlands). Kinetochores were classified on the basis of
their appearance in maximal projection images incorporating 10×50 nm
z-sections above and below a manually marked point where the kinetochore/
kinetochore pair appeared (covering a z-distance of 1.0 µm). To distinguish
overlapping kinetochore pairs from single kinetochores, we used 3D
reconstructions in Imaris (Bitplane, Zurich, Switzerland) to examine them
in their chromosomal context. If foci could not be reliably classified, for
instance due to overlapping chromosomes or kinetochore signal, they were
classified as unclear. Inter-kinetochore distance was measured using the
FindFoci plugin in ImageJ, which identifies regions of peak intensity in 3D
image stacks (Herbert et al., 2014). For kinetochores in different z-sections,
the Pythagorean formula was used to calculate inter-kinetochore distance.
Statistical analysis of inter-kinetochore measurements was performed in
Excel (Microsoft) or R (http://www.r-project.org/).
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Fig. S1. Left: maximal projection of MI oocyte chromosomes. Right: z-projection images incorporating 
20x50 nm z-sections centred about a manually marked kinetochore pair (centre of panel). Green bar 
marks ‘overlapping’ kinetochore pairs. Sister kinetochore pairs on homologous chromosomes are 
shown in right and left panels. Panels are 4x4 µm.
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Table S1. Reasons for treatment in the women donating oocytes to this study 
Patient 
number 
Woman’s 
age at egg 
collection 
Pre-treatment 
parity of female 
partner 
Reason for treatment Outcome of 
treatment 
cycle 
1 27.7 0+0 Same-sex female couple Neg 
2 28.6 0+0 Male factor infertility 1FH 
3 39.0 0+0 Unexplained infertility Neg 
4 39.0 0+0 Unexplained infertility Neg 
5 28.1 0+0 Polycystic ovarian disease 1FH 
6 29.1 0+1 Azoospermia 1FH 
7 38.4 0+0 Unexplained infertility 1FH 
8 32.4 0+0 Tubal factor Neg 
9 40.7 0+3 
Recurrent miscarriage plus 
unexplained subfertility 2FH 
10 32.4 0+0 Uterine factor 1FH 
11 38.3 0+0 Unexplained infertility 1FH 
12 34.9 0+0 Male factor infertility 1FH 
13 30.2 0+0 Polycystic ovarian syndrome Neg 
14 39.8 1+1 Endometriosis, bicornate uterus Neg 
15 35.1 0+0 Polycystic ovarian syndrome Neg 
16 26.2 0+0 Endometriosis 1FH 
Women with no known fertility issues, whose partner’s infertility or absence of a male partner
may explain the couple’s infertility, are highlighted in grey. Patients 2, 5, 6, 7, 9, 10, 11, 12, 14 
and 16 have demonstrated fertility by becoming pregnant either as a result of treatment or 
previously. Parity data is shown as parity (number of births >24 weeks) + gravidity (number of 
pregnancies). FH = fetal heart visible on ultrasound scan. Neg = no pregnancy. 
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Appendix C. Documentation 
i. HFEA Licence Centre 0013
ii. HFEA Licence Centre 0320
iii. HFEA Licence Centre 0340
iv. Patient information sheet
v. Patient consent form
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University Hospital 
Clifford Bridge Road 
Coventry 
CV2 2DX 
Tel: 024 76964000 
Version 6. 13 March 2014 
PATIENT INFORMATION SHEET 
Indicators of oocyte and embryo development 
Dear Patient 
You are being invited to take part in a research study. 
Before you decide, it is important for you to understand why the research is being done 
and what it will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear or if you 
would like more information.  Take time to decide whether or not you wish to take part. 
Your decision in this respect will not affect your treatment at all.   
If you do choose to participate in the research, you still remain free to withdraw your 
consent at any time before your material has been used in the research.  Such 
withdrawal of consent will have no effect on your treatment or care. 
Thank you for reading this.  
Yours faithfully 
 Geraldine Hartshorne 
Scientific Director 
Centre for Reproductive Medicine 
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WHAT IS THE PURPOSE OF THE STUDY? 
We are doing research to understand better how eggs and embryos are formed and 
grow.  This is an ongoing study that has been in progress since 1996 and will continue 
until at least 2017.   
At present, it is very difficult to identify the embryos that are most likely to implant when 
placed into the womb during fertility treatments.  There are few markers that show clearly 
whether an egg or embryo is growing well.  Moreover, it is possible that development 
could be affected by the laboratory environment because it is different to the 
environment in the body.  For the future, we want to be able to tell whether eggs and 
embryos in our laboratory are growing well and whether any problems have arisen for 
any reason.  To do this, we need to study eggs and embryos in great detail and using a 
variety of different scientific methods.  This will tell us, for example, whether certain 
specialised molecules produced by the embryos or attached to the chromosomes, are 
behaving normally.  We hope that in future, it may be possible to test embryos for these 
features to monitor normal development, and to check the risks of any new methods of 
fertility treatment that might be invented.  We shall also collect digital images of embryos 
in order to construct virtual reality models for use in further research to develop new 
educational resources.   
Why have I been chosen? 
We would like to ask if you would be willing to let us use some of your eggs or embryos 
for our research.  This would not affect your treatment at all as we would only use any 
‘left-overs’ for research.  These would normally be discarded.  We would only use them 
in research if you agree and sign your consent on the form.   
If you agree, we would like to use immature eggs (that cannot be used for treatment), 
eggs that do not fertilise normally, and poorly developing embryos that would not be 
stored frozen.  Once you have finished your treatment, we would also like to use any 
embryos that you may have left over in the freezer.   
None of the eggs or embryos would ever be used to treat anyone else or to make a 
pregnancy.  Please note that eggs or embryos in a non-viable state may be taken to 
other research centres for study, such as the Universities of Warwick, Sussex, London or 
Paris, as the specialised equipment that we need to use is based there.  Please be 
assured that any samples moved to other centres would be treated there with the same 
respect as if they remained here.  All the samples will be anonymised so that your 
personal details would only be accessible under strictly controlled conditions and then 
only to Trust personnel who are already authorised to access your medical records. 
Also, please note that any immature eggs that become mature in the laboratory under 
specialised conditions may be injected with sperm from a donor to see if they will fertilise.  
Any embryos formed in this way could only develop for a day or two at most because the 
eggs would have already deteriorated.  They would be incapable of normal development 
and would not be available to you or anyone else for treatment since they would be 
created using research methods.   
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Do I have to take part? 
Participation is entirely voluntary and your decision in this respect will not affect any 
aspect of your treatment or its outcome.   
What will happen to me if I take part? 
Your treatment will proceed exactly the same way, whether or not you choose to take 
part.  However, if you choose to participate, the embryologists in the laboratory will 
identify any of your eggs and embryos that cannot be used for your treatment and would 
otherwise be discarded.  These would then be made available to researchers working on 
this project.   
Only some patients will have any eggs or embryos left over, so not everyone is suitable 
to participate.  This depends upon the type of treatment that you are having and what 
happens during your treatment.   
What do I have to do? 
Please take time to read the information and discuss with a member of staff any 
questions that you may have.  If you wish to take part, please complete and sign the 
consent form.  For use of eggs, only the woman needs to sign, but for use of embryos, 
both of the couple need to sign.   
What are the possible benefits and risks of taking part? 
There are no benefits to you personally of taking part.  In future we hope that this 
research may bring benefits to other people going through fertility treatment.   
There are no risks of this study over and above those of the treatment itself.   
What happens when the research study stops? 
At the end of this study, any eggs and embryos that have been used for research are 
normally disposed of.  However, if you agree, it is possible that they can be kept in case 
they could be useful for other research projects in future. We would like to keep them for 
this purpose, however, you are under no obligation to agree to this, regardless of 
whether you agree to participate in the present study.  Please would you indicate on the 
consent form whether you agree for this to be done.  Rest assured that any such future 
research would be approved in advance by the Local Research Ethics Committee.   
What if something goes wrong? 
We do not envisage any problems arising during the course of this research.  However, if 
an untoward event were to occur, please be assured that we will do everything we can to 
put matters right.  You have a right to complain to the hospital through the normal NHS 
complaints procedure.  If you wish to complain, please write to the hospital complaints 
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officer at the address above.  In addition, you are also welcome to contact the Human 
Fertilisation and Embryology Authority which regulates research such as this.  Their 
address is:  10 Spring Gardens, London, SW1A 2BU.   
Will my taking part in this study be kept confidential? 
Yes, your participation will be confidential.  Any samples you provide and non-identifying 
information from your medical history will be stored in an anonymous form. Please note 
that such anonymised information may be stored on a computer database.   
What will happen to the results of the research study? 
The results will be published in a medical journal and presented to learned societies at 
conferences, but you would not be identified in any publication.  The information that we 
gain will be of no use to you personally so we do not plan to tell you about it.  But if you 
would like a copy of the final publication, please write to the principal investigator at the 
address above.  Please note, it usually takes several years for results to be fully 
analysed and published.   
It is possible that some of the results could be used to develop a virtual reality tool which 
might result in intellectual property rights, and possible financial benefit in the future, for 
some of the researchers.  
Who is organising and funding the research? 
This study is currently not receiving any specially allocated financial support or 
sponsorship.A small amount of general research funding is available through the Centre 
for Reproductive Medicine, allowing us to make some progress.  No inducement or 
financial reward will be given to any of the staff involved in recruiting patients for this 
study.  
If you would like to take part, please complete the consent form. You will be given the 
information sheet and a copy of the signed consent form to keep.  
If you have any questions or queries, or decide to change your mind, please ask one of 
the staff, or contact: 
Dr Geraldine Hartshorne 
Scientific Director 
Centre for Reproductive Medicine 
UHCW NHS Trust, Coventry, CV2 2DX 
Tel:  02476 968879.   
You are also very welcome to contact the centre’s independent counsellor for any 
reason.  Making decisions about the use, donation or disposal of eggs or embryos can 
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be difficult.  The counsellor is experienced in helping people with various queries and 
personal questions.  She can be contacted directly on telephone number 02476968886.   
Thank you for your help. 
The Trust has access to interpreting and translation services.  If you need this 
information in another language, please contact the Quality Manager on (024) 76968864, 
and we will do our best to accommodate your needs.  The Trust operates a smoke free 
policy. 
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University Hospital 
Clifford Bridge Road 
Coventry  CV2 2DX 
Tel: 024 76 965000 
Indicators of Oocyte and Embryo Development 
Centre Number:      0013         
Study Number:      04/Q2802/26 
Name of Researcher:  Dr Geraldine Hartshorne 
      Please initial box 
1. I confirm that I have read and understand the Information
sheet dated 13 March 2014 (version 6) for the above study and
have had the opportunity to ask questions……….…………………….. 
2. I understand that my participation is voluntary and that I am free to
withdraw (by written confirmation to the principal investigator) at any
time until any samples are used, without giving any
reason.  My medical care or legal rights will not be affected……..….. 
3. I understand that responsible individuals at the Centre for
Reproductive Medicine may look at my medical notes. I give
permission for them to collect anonymised medical history data……… 
4. I agree to take part in the above study…………………………………… 
5. I wish to offer the following material to research
• Eggs (immature or unfertilised)……………………… 
• Fresh embryos (unsuitable for cryopreservation)…... 
• Frozen embryos (no longer required)………… 
6. At the end of the study, I agree that my anonymised material
can be kept for future research……………………………………………. 
_________________________ ________ _______________________ 
Name of Female Patient   Date                      Signature 
_________________________ ________ _______________________ 
Name of Male Patient      Date                      Signature 
_________________________  ________        ________________________ 
Name of Person taking consent  Date Signature 
(if different from researcher) 
_________________________ ________        ________________________ 
Researcher  Date Signature  
1 for patient 1 for researcher  1 to be kept with hospital notes 
consent form version 6, 13 March 2014 
